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1.      INTRODUCTION 
 
The field of oncology has expanded drastically in the past decade, in terms of both 
treatment options and expertise. Most of these options while improving overall survival 
and / or quality of life have increased the total expenditure of cancer treatment. 
The treatment options in breast cancer, a common cancer among women, are an 
example of this expansion that has occurred in the world of oncological treatments. We 
have moved from the era of radical surgeries to breast conservations, from CMF regimen 
of chemotherapy to anthracyclines and taxanes, various hormonal and targeted therapies, 
conventional radiation therapy and 3D conformal tangents to intensity modulated 
radiotherapy with image guidance, tomotherapy and gated radiotherapy. 
Various studies have portrayed the benefits of intensity modulated radiotherapy 
over 3D conformal tangents as the technique of radiation delivery for post-mastectomy 
chest wall, while mentioning that respiratory movement is a major area of concern(1). 
Hence, before moving on to higher technologies such as IMRT or Tomotherapy, it was 
important to compare the new technology (IMRT) with the standard technique (3D 
conformal tangents) taking into account the effect of respiration. This was increasingly 
important in our society where finances are still limited. 
It is predicted that the effect of respiratory motion on IMRT plan may be more in 
patients with larger chest wall movement or tidal volume while respiratory motion may not 
affect 3D-CRT as much. Hence, this study was designed to correlate the magnitude of 
respiratory motion and its effect on IMRT versus 3D-CRT plan. 
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2.      REVIEW OF LITERATURE 
2.1    BREAST CANCER WORLD WIDE 
Cancer of the breast in women is a major health burden worldwide. It is the most 
common cancer among women as well as the primary cause of cancer death among women 
globally (22.9% of all new cancers in women and 13.7% of cancer deaths)(2). The 
incidence of breast cancer has increased considerably over the past few decades. It doubled 
between 1975 and 2000 and seems to double again between then and 2030(3). There is no 
population around the world with a low risk for breast cancer and this doubling is predicted 
to affect the lower income and lower middle income countries the most. 
 
 
Figure 2.1: Estimated age standardised incidence rate of  breast cancer per 
100,000 population around the World, all ages (4) 
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2.2    INDIAN SCENARIO  
In the past the incidence of breast cancer in India was low. But with the turn of the 
century incidence of breast cancer has been steadily rising. The Indian cancer registries 
have shown a hike of about 0.5% per year incidence between the years 1991-2005 and it 
varies greatly between the urban and rural areas of India. The Mumbai cancer registry 
shows an increase of 1.1% per annum over a 30 year period from 1975-2005(5). National 
Cancer Registry Program (2006- 2008) reported an incidence of 33 and 32.1 per 100000 
population in Mumbai and Chennai, while Pune and Bhopal had an incidence of 24.4 and 
25.5 per 100000, and the rural India had an incidence of 7.4 per 100000 (NCRP, 
unpublished data). This variation across our country has hindered the widespread use of 
newer technologies in the treatment of breast cancer. 
Unlike the western population, most patients have locally advanced disease at 
presentation. Hence, modified radical mastectomy is the most commonly practiced surgery 
for breast cancer in India. 
Table 2.1: The stage at presentation of breast cancer in various cities of India(6) 
Stage 
Frequency in Percent 
Mumbai  Trivandrum  Chennai Lucknow 
I 7.8 4.4 1 4 
II 57.4 42.3 23 33 
III 28.9 40.5 52 47 
IV 5.9 12.8 24 9 
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2.3     OVERVIEW OF BREAST CANCER MANAGEMENT 
The management of invasive breast cancer is based on the clinical extent and 
pathological characteristic of tumour, in addition to the age of patient (menopausal status), 
biological prognostic factors and preference of the patient. 
Although surgery is the mainstay of treatment in non-metastatic breast cancers, the 
other modalities including chemotherapy, endocrine therapy, targeted therapy and radiation 
therapy have added benefits if administered according to the indications. There are various 
prognostic factors which determine the sequence and combinations of therapy.  
Introduction of multimodality treatment (surgery, chemotherapy and radiation therapy) 
reduced breast cancer mortality by 18% and improved overall survival(7).  
In the recent years a paradigm shift has occurred in the surgical management of 
breast cancers, from radical mastectomy to breast conservation surgeries in the early stage 
breast cancer and issues regarding quality of life are given equal importance to overall 
survival. The novel molecules (hormonal / targeted therapies) and chemotherapeutic drugs 
have improved overall survival with tolerable side effects. At the same time, advanced 
radiation therapy techniques have made treatment of post-mastectomy chest wall and post 
breast conservation whole breast treatments more effective.   
2.4   ROLE OF RADIATION THERAPY IN BREAST CANCER 
The use of radiation therapy in the treatment of breast cancer dates back to as early 
as 1890’s. The first X-ray machine was assembled in Chicago in 1896 by Emile Grubbe 
and it has been documented that a patient with recurrent breast cancer was treated in the 
same year. 
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In the present era, radiation therapy plays a major role in the treatment of both early 
stage and locally advanced breast cancers. In early stage of breast cancer, it forms a major 
part of breast conservation therapy while in locally advanced stage, post mastectomy 
radiotherapy is indicated only in high risk patients (especially for tumours > 5cms in size 
and > 4 nodes positive disease). 
However, in India, mastectomy is still the most common and this is because of the 
following  factors  
1. Tumour factors: locally advanced nature of disease at presentation 
2. Patient factors: - 
 Concerned about disease free survival than cosmetics 
 Finances 
 Poor adherence to follow up regimes 
3. Physician factors: - 
 Surgical skill and radiotherapy equipment required for breast 
conservative therapies are not easily accessible across centres in India. 
Adjuvant radiation therapy in breast cancer not only involves treatment of chest 
wall/ breast, but also the draining lymph nodal regions according to specific indications. 
Radiation to chest wall/ breast in itself is challenging as it involves treatment of a strip of 
curvilinear structure while sparing the underlying lungs and heart. Treatment of adjacent 
lymph node regions makes radiation therapy planning in breast cancers more complex. 
Post mastectomy radiotherapy: - The indications for post mastectomy radiation 
therapy have been defined from the results of various randomized trials like the Danish 
trial and British Columbia trial. Benefit in terms of local control and survival was found in 
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stages II / III and node positive breast cancers(8,9). Studies showed that the addition of 
post mastectomy radiotherapy reduced loco regional recurrence rate by 2/3rd to3/4th when 
compared to the groups that did not receive radiotherapy(10,11) 
On the other hand, the role of post mastectomy radiotherapy in T1/T2 tumour, grade 
1 / grade 2 with 1-3 lymph nodes positive is still debatable.  The indications in this group 
of breast cancers is expected from the results of the on-going Supremo trial(12). Various 
factors such as size of tumour (>4 cm), close/positive margins, lymph vascular invasion, 
extra capsular extension, ER/PR/Her2 neu status, grade of tumour are known to affect the 
loco regional recurrence rate, and these factors contribute significantly towards the decision 
making. 
Various techniques of post mastectomy radiation therapy are available, such as 
external beam therapy with photons / electrons. Single or a combination of techniques is 
used and all modalities aim at maximizing dose to chest wall while minimizing dose to 
underlying critical structures such as lungs and heart. 
Within external radiotherapy, the technological improvement has provided us with 
various approaches to deliver the radiation dose. A few of them are: 
 Conventional therapy with tangential beams 
 Electron Therapy 
 Conformal therapy 
 Intensity modulated radiotherapy 
 Image guided radiotherapy 
 Arc therapy (Volumetric Modulated Arc Therapy –VMAT) 
 Tomotherapy 
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Organs at risk in post-mastectomy radiotherapy and its effect: 
1. Lungs-  
The incidence of radiation pneumonitis is low in chest wall only radiotherapy but 
the addition of supraclavicular and axillary radiation has shown to increases its incidence.  
Hockey stick radiation field which includes inter-mammary lymph nodal irradiation further 
increases its incidence. In the British Columbia experience, it has been documented that 
1/164 patients treated with sequential chemotherapy and radiotherapy developed 
symptomatic radiation pneumonitis requiring corticosteroid therapy(13). The characteristic 
clinical features of radiation pneumonitis are cough, fever and non-specific infiltrates on 
Chest X-ray. 
Table 2.2: RTOG clinical grading of Radiation pneumonitis 
Grade Definition 
1 
Mild dry cough or dyspnoea on exertion requiring clinical 
intervention 
2 Cough requiring narcotic anti-tussives or dyspnoea not at rest 
3 
Severe cough not responding to narcotics or  dyspnoea at rest;  
Intermittent oxygen or steroids may be required 
4 Continuous oxygen or assisted ventilation 
5 Fatal 
 
2. Heart- 
Though infrequent, acute and subacute complications of post-mastectomy 
radiotherapy such as pericarditis and cardiac failure have been reported. At the same time, 
long term complication of cardiac related morbidity has been reported more commonly. A 
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meta-analysis of 10 randomised trial of PMRT has shown that the standard mortality ratio 
for heart disease was 1.62 times higher for irradiated patients (p<0.01)(14). Though there 
are various factors such as chemotherapeutic regimen used and patient’s comorbid illnesses 
that add to the risk of long term cardiac toxicity, the most important treatment related factor 
is the volume of heart irradiated. Volume of heart irradiated increases considerably when 
internal mammary lymph nodal irradiation is done. 
Recent studies have shown that the doses to the heart from PMRT can be 
considerably reduced by using megavoltage energies and modern planning techniques. 
3. Brachial plexus- 
Injury to brachial plexus in patients treated for breast cancer may be multifactorial 
(axillary surgery, radiation therapy and chemotherapy). However incidence of brachial 
plexopathy due to radiation therapy is rare and is related to the use of a third field 
(supraclavicular +/- axillary fields) and dose to axilla. In the JCRT (Joint centre for 
Radiation therapy) experience, where axillary dose was less than or equal to 50 Gy, the 
incidence of plexopathy was only 0.6% in the absence of chemotherapy and 4.5% with 
chemotherapy(15). The rate of permanent plexoplathy was also dependent on delivered 
dose and fraction size 
4. Contralateral breast 
Women with breast cancer have a baseline risk of developing contralateral breast 
cancer at the rate of 0.3% to 1% per year(16,17). Various cancer registries and case control 
studies have revealed a slightly increased risk in women treated with radiation therapy(18). 
This increased risk may be due to the small dose of scattered radiation deposited in the 
contralateral breast during radiation. However, this increased risk seems to be confined to 
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patients younger than 40-45 years of age at the time of treatment. The analysis of 
Connecticut Tumour registry, revealed that patients of age 45 or younger at the time of 
radiation exposure had an increased relative risk of 1.59 (95% confidence interval- 1.07 to 
2.36) and, at an average dose of 1 Gy delivered to contralateral breast, the estimated relative 
risk was 1.21(19). 
2.5   RADIATION THERAPY TECHNIQUES IN BREAST CANCER 
(POSTMASTECTOMY SETTING) 
 
1. Conventional therapy - Tangents:  
The chest wall has been conventionally treated with 2 tangential beams in contrast 
to AP-PA beams, in order to reduce the dose to lungs and heart. Various parameters such 
as Central Lung Distance (CLD), Maximum Lung Distance (MLD), Average Lung 
Distance (ALD) and Maximal Heart Distance (MHD) are measured from a simulator film 
to predict the volume of lung and heart being irradiated, which in turn predicts the 
probability of radiation induced pneumonitis or cardiac toxicity. A CLD of 1.5cm, 2.5cm 
and 3.5 denotes the involvement of 6%, 16% and 26% of lung respectively and a CLD of 
than 3 cm in left side breast cancer, resulted in irradiation of a significant volume of heart. 
Similarly, grouped ALD (average of superior and inferior lung distance) values of  < 2 cm, 
2-3 cm and > 3 cm show an increasing trend of radiation pneumonitis of 4%, 6% and 14% 
respectively, though not statistically significant(20).  
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Figure 2.2: Computerised radiograph showing medial tangential view of a whole breast 
radiotherapy plan with the various parameters of plan evaluation such as CLD (central 
lung distance) and MHD (maximum heart distance) marked. 
 
2. Conformal Radiotherapy 
The concept of CT based volume delineation and planning was introduced in the 
late 80’s when a CT extension of X-ray simulator was enabled. This improved field set up 
and dose calculations, though only limited CT slices were available. However, the optimal 
use of 3D based planning became possible when CT simulators replaced X-ray simulators 
and dose calculations were no more based on target volume alone but also on normal tissue 
constraints.  
A conformal therapy plan employs the use of multiple tangential beams of varying 
weightage to produce homogenous coverage of target volume as well as sparing of normal 
tissues.  
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Figure 2.3: An axial section of thorax showing a 3D conformal therapy dose distribution.  
The 95% isodose line is covering the target as well as neighbouring normal tissue. 
 
The assessment of dose delivered to target volume or normal tissue by conventional 
two dimensional planning is highly inadequate as it is based on rough estimates. 
Meanwhile, 3 dimensional treatment planning allows more accurate analysis of dose to 
target as well as normal tissue with the aid of dose volume histograms (DVH). In addition 
to the availability of DVH, analyses of plans allows the use of biologic effect models, such 
as normal tissue complication probability (NTCP) models to estimate toxicity risk. 
Therefore, 3D treatment planning is a powerful tool that can compare treatment techniques 
for adequacy of target coverage and complication risk. 
Treatment of chest wall and regional lymph nodes pose many challenges to 
Radiation Oncologists. There is no single technique accepted as gold standard and hence 
multiple complex field arrangements have been used for treatment.  These have led to high 
radiation dose to large volumes of heart and resulted in increased rates of pericarditis(21). 
Radiation induced ischemic heart disease is also a significant treatment related 
morbidity(14). 
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Similarly, risk of radiation pneumonitis also limits the choice of radiation 
techniques depending on the body habitus and in field lung volumes. 
The risks of cardiac and pulmonary toxicities are highly dependent on the dose 
received by the organ and this is dependent on the technique of radiation delivery. Hence 
accurate estimate of these risks are crucial for decision making when selecting the fields 
arrangement for treatment. Though theoretically 3D conformal tangents technique involves 
a reduction in the volume of normal tissue receiving high dose, these beams of uniform 
intensity result in lung toxicity which is directly proportional to the volume of lung within 
the radiation field.  
3. Intensity modulated radiotherapy 
Since 1960’s physicists have attempted to develop ways and means of altering the 
spatial distribution of the intensity of treatment beams. Initially, metallic beam modifiers 
were used for this purpose. These resulted in better coverage of dose to targets. Beam 
blocks, wedge filters, bolus and beam compensators were the beam modifying devices that 
were used in 2- dimensional and 3- dimensional radiotherapy till the 1990’s. It was then 
that computer controlled Linear Accelerators with fully motorised Multi-Leaf Collimators 
were launched and 3D treatment planning computers with inverse planning algorithms for 
optimisation of dose were developed. New Linear Accelerator based IMRT  treatment 
delivery systems including binary multi-leaf intensity modulating collimator, step and 
shoot MLC, dynamic MLC and intensity modulated arc therapy were developed. Two other 
types of IMRT equipment, namely Cyber Knife and Helical Tomotherapy have also been 
launched and are commercially available. 
Dosimetrically, IMRT has the ability to deliver the prescribed dose to the delineated 
target volume with precision, while sparing the adjacent normal tissue structures. It 
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basically differs from common tangent based plan by having multiple beams which are 
directed to the target from all around and these beams are further modulated in their 
intensity by the moving multi-leaf collimators. A computer aided optimization process is 
used to determine customized non uniform fluence distributions to attain certain specified 
dosimetric and clinical objectives.   
 
Figure 2.4: A three dimensional view of nine axial beams showing beamlet 
intensities around the chest wall target (pink). Other structures shown are heart (yellow), 
supraclavicular nodal region (blue), internal mammary chain (red) and spinal cord 
(green)(22) 
Benefits of intensity modulated radiotherapy in post mastectomy breast cancer: 
There is a significant body of literature showing that inverse planned intensity modulated 
radiotherapy leads to a more favourable dose distribution compared to 3 dimensional 
planned conformal radiotherapy of whole breast after breast conservation (23–28)]. Data 
on IMRT of the chest wall in post-mastectomy breast cancer patients are scarce in 
literature. However, there are distinct differences in the target volume of conserved breast 
and chest wall. The shape of the target (chest wall) is usually shallower. In addition, while 
contouring for whole breast radiotherapy, the pectoralis muscles, chest wall muscles and 
ribs may be excluded in stage I-IIA breast cancers, whereas these structures are included 
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in the target volume of chest wall. Due to these differences, results of a dosimetric study 
on radiotherapy to whole breast are not completely applicable to radiotherapy of the chest 
wall. 
Hence, a focussed literature review on intensity modulated radiotherapy in post 
mastectomy breast cancer was done and it revealed that there was definite benefit of the 
same when compared to 3DCRT, such as: 
1. Tangential field IMRT reduces the ipsilateral lung dose volume (D30 by 43%) 
when compared to 3DCRT tangents. 
2.  Tangential field IMRT reduces the heart dose volume in the left sided breast 
cancer patients (V70 by 46%) when compared to 3DCRT tangents(1).  
3.   Further search projected the benefits of IMRT technique when regional lymph 
nodal irradiation was required along with chest wall irradiation.  
The known pitfalls in conventional radiotherapy in this setting are:  
1. Under / over-dosage at the junction of the matched chest wall and 
supraclavicular fields 
2. Inhomogeneous distribution due to matching of separate fields for regional 
lymph nodes irradiation 
3. Under-coverage due to the routine mean depth to which the dose to regional 
lymph nodes is prescribed- as the depth varies from person to person. 
IMRT technique was able to overcome these pitfalls and provide a homogenous 
dose to the various targets (chest wall and regional nodal area) while maintaining a similar 
dose to normal tissues. In fact, IMRT technique was able to reduce the V20 (volume 
receiving 20 Gy) of ipsilateral lung to 28% when compared to 32% - 45% with 3D 
conformal technique(29). 
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Issues in clinical implementation of Intensity modulated radiotherapy, especially in 
post mastectomy treatment are: 
1. High cost 
2. Complex and time consuming procedures 
3. Dedicated quality assurance programs 
4. Management of inter-fraction changes- set up errors 
5. Management of intra-fraction changes- movement with respiratory motion 
Hence, though IMRT is theoretically capable of delivering conformal dose with 
high degree of precision, it may not be true clinically due to various uncertainties in the 
radiotherapy process. 
2.6    UNCERTAINTIES IN RADIATION THERAPY FOR BREAST 
CANCER 
 
1. Set up errors: 
 Studies have shown wide variations in systematic errors of 1.0-14.4 mm and 
random errors of 1.7-5.8 mm in tangential breast / chest wall radiotherapy(30). The use of 
immobilisation devices have significantly improved set up reproducibility in breast cancer 
treatments. Various immobilisation devices have been examined, such as wedge boards 
with or without arm supports, cushion with arm handle, plastic mask, vac-fix etc. It was 
also established that arm handles further reduced set up errors(31). 
2. Respiratory motion induced errors:  
Breast / chest wall is mobile during respiration with a motion amplitude as high as 
0.8 to 10 mm in the antero-posterior direction(32). This movement is capable of 
contributing significantly to geometric uncertainties. 
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Most research on respiratory motion in breast cancer radiotherapy has been done 
on conserved breasts. One of them established the set up deviation as well as breast 
movements during normal and deep breathing with and without respiratory training. The 
mean set up deviation was 1.3 mm (SD+/-0.5 mm), 1.3 mm (SD +/- 0.3 mm) and 4.4 mm 
(SD +/- 2.6 mm) in the medio-lateral, supero-inferior and antero-posterior dimensions 
respectively. The mean set up deviation was added to the post training breast movement to 
give the cumulative maximum movement error (CMME). The mean CMME was recorded 
for a group of 5 patients as 3.4 mm, 4.5 mm and 7.1 mm in the medio-lateral, supero-
inferior and antero-posterior dimensions respectively(33). Though these values aren’t 
directly applicable in the post-mastectomy setting it gives an idea regarding set up 
deviation as well as breast movement with respiration.  
2.7    RESPIRATORY MOTION AND IT EFFECT ON RADIATION 
THERAPY FOR BREAST CANCER 
 
1. Image acquisition limitations 
If respiratory motion is not accounted for during imaging, motion artefacts are 
created which distort the target volume. 
2. Treatment planning limitations 
Planning Target Volumes (PTV) should be large enough to ensure target coverage 
through the treatment delivery. In case of post mastectomy breast cancer, expanding the 
target volume to account for respiratory motion would mean extending anteriorly into air 
and posteriorly into lung. This increases lung dose. This expansion is not entirely possible 
in IMRT planning. A technique of skin flash is used to account for anterior shift with 
respiration. 
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3. Radiation delivery limitations 
Radiation delivery in the presence of organ motion causes an averaging or blurring 
of static dose distribution over a path of motion. This displacement results in deviation 
between intended and delivered dose distribution. For non IMRT / conventional radiation 
where the dose gradient in the center of field is small, the effect is manifested by blurring 
of dose distribution with anatomy moving near the beam edge. This effect may be 
exacerbated in IMRT delivery due to its conformal nature and steep fall off of dose 
gradient. 
Analysis of inter-fraction and intra-fraction variation during tangential breast 
radiotherapy using Electronic Portal Imaging Device (EPID) revealed the effect of 
respiratory motion and movement during treatment was minimal. The maximum range of 
central lung distance for any patient on one day was 0.25 cm. However, the day to day set 
up variation was greater, with CLD values ranging from 0.59 cm to 2.94 cm and it resulted 
in change in corresponding lung and heart areas during individual treatment fractions(34).  
2.8    MAGNITUDE AND MEASUREMENT OF RESPIRATORY 
MOTION 
 
1. Mechanics of breathing 
The lung primarily functions to facilitate gas exchange (O2 and CO2) between blood 
and air, thereby maintaining normal pressure in arterial blood. Respiration being an 
involuntary movement continues even if the person is unconscious and breathing is non-
rhythmic, unlike cardiac motion. Nevertheless, it is possible to control the pattern of 
breathing. 
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Respiration is composed of 2 components, inspiration and expiration. The 
diaphragm is the most important muscle of inhalation. As the diaphragm contracts it forces 
the abdomen inferiorly and anteriorly, thereby increasing the size of chest cavity in the 
supero-inferior direction. The intercostals muscles which connect the ribs also play a part 
in normal inspiration. Contraction of these muscles, cause the chest wall to expand antero-
posteriorly. Exhalation on the other hand is a passive process where in the lungs recoil into 
their pre inspiration position. 
 
Figure 2.5: (a) During inhalation, the diaphragm contracts, the abdomen is forced 
down and forward, and the rib cage is lifted.  (b) The intercostal muscles also 
contract to pull and rotate the ribs, resulting in increasing both the lateral and 
anterior- posterior (AP) diameters of the thorax(35) 
 
2. Measuring respiratory motion: 
Person’s breathing pattern varies in magnitude, regularity and period. It varies from 
person to person as well as time to time in the same person. Respiratory motion varies 
markedly between persons that an individual approach to respiratory management is 
advised. Audio-visual feedback has demonstrated to improve respiratory reproducibility. 
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3. Motion observables 
There is no fixed pattern of respiratory behaviour for a particular person prior to 
observation and treatment. Each person differs in terms of quiet versus deep, chest versus 
abdominal and healthy versus compromised. Hence, it has been shown that every person’s 
respiratory pattern has to be analysed prior to treatment. 
Both surface markers and spirometers provide signals that are surrogate of tumour 
motion. Their applications should be validated by performing fluoroscopic and CT imaging 
studies. 
2.9 RESPIRATORY MOTION AND ITS EFFECT ON INTENSITY 
MODULATED RADIOTHERAPY FOR   BREAST CANCER 
 
As mentioned earlier, IMRT is gaining popularity owing to its ability to conform 
the spatial distribution of the dose deposited in a patient more effectively especially in case 
of targets in thoracic cavity and abdominal cavity where the organs at risk are many. 
However respiratory motion is thought to hinder the actual benefit of IMRT. In IMRT, 
beam intensity gradients are not limited to beam edges. Thus respiratory motion may result 
in major dose variations. This effect will be exacerbated by the interplay between motion 
of leaves of multileaf collimators and component of target motion perpendicular to the 
beam. 
Various studies have also documented dosimetric errors using single MLC based 
IMRT treatment, summing upto 20% within the field (in low dose gradients) and even 
higher in the edge of the field (high dose gradient region). These studies were film based 
and didn’t take into account target deformation(36,37). Thus effect of respiratory motion 
on dose is of prime concern in IMRT. 
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Yu et al demonstrated that fluence variations within the target tend to average out 
over a typical course of 25-30 fractions(38). ]. This was confirmed by other studies also. 
However, these studies assumed 1 dimensional movement and didn’t take into account 
target deformation. Thus it was concluded that fractionation alone cannot be relied upon, 
especially for movement > 1cm. 
From the literature we know that the mean amplitude of chest wall movement with 
respiration is 8-10 mm.   Considering the small amplitude, the influence of respiratory 
motion on dose may not be marked.  However, it can be postulated that patients with large 
chest wall movement with respiration (8 mm) are likely to have significant target under-
coverage. This may also reflect as over-dosage to organs at risk. 
2.10 RESPIRATORY MOTION MANAGEMENT TECHNIQUES AND 
ITS BENEFITS IN BREAST CANCER RADIOTHERAPY 
 
Techniques: 
1. Motion encompassing methods 
The 3 techniques possible for acquiring CT scan that accounts for motion are 
 Slow CT scan 
 Inhale and Exhale breath hold technique 
 4D CT scan 
2. Respiratory gating methods 
Respiratory gating involves delivering radiation only within a particular 
predetermined phase of breathing cycle. The position and width of this phase also called a 
gate is determined by monitoring the patient’s respiratory motion, using an external 
surrogate marker or internal fiducial. It requires special equipment to track the target in the 
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form of external markers or internal fiducials and increases the overall treatment time. This 
is more pronounced in case of IMRT where the overall treatment time increases by 4-15 
fold over a conventional treatment.  
3. Breath hold methods 
It was found that breath hold techniques (in deep inspiration) facilitated the 
movement of heart posteriorly and inferiorly away from the chest wall thereby reducing 
the cardiac and pulmonary toxicity. However, these techniques required meticulous 
training of the patient and the compliance was poor. 
It is possible to incorporate breath holds into IMRT delivery sequence, that is to 
segment the leaf motion sequence into active and inactive periods corresponding to the 
breath hold and rest periods.  
4. Real time tumour/ target tracing methods 
 More sophisticated than breath-hold technique incorporated into IMRT delivery 
sequence are methods that involve synchronization of IMRT delivery with respiratory 
motion. The advantage of this method is that patient is allowed to breathe freely, and linear 
accelerator operation may not be interrupted. 
Benefits of respiratory motion management techniques: 
 The use of respiratory gating technique has proven to reduce the dose delivered to 
the heart in breast radiotherapy especially in left sided breast cancer patients. There was a 
15.5% decrease in average mean dose to the heart(39). Similarly Korreman et al showed 
that DIBH (deep inspiratory breath hold) technique and IG (inspiratory gating) technique 
decreased the incidence of pneumonitis(40). 
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2.11 RESPIRATORY MOTION MANAGEMENT TECHNIQUES IN 
THE INDIAN SCENARIO OF BREAST CANCER 
 
 As seen above, respiratory motion management techniques either needs meticulous 
patient training, patient cooperation and/ or sophisticated tumour tracking equipment. In 
addition, it is a time consuming process which requires considerable human resource as 
well as machine time. Thus its relevance in the Indian scenario of high patient load and 
poor finances is questionable. 
2.12 CHOICE OF RADIATION THERAPY TECHNIQUE FOR 
BREAST CANCER ON THE BASIS OF RESPIRATORY MOTION 
 
 As respiratory motion management techniques are still limited to a few selected 
patients especially in India, the options of radiation therapy technique is restricted to 3D 
conformal tangents and Intensity modulated radiotherapy. This study aims at formulating 
a protocol for selection of appropriate radiation therapy technique on the basis of patient’s 
respiratory pattern. 
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3.     MATERIALS AND METHODS 
3.1      AIMS AND OBJECTIVES 
Aim: To study the dosimetric effect of respiratory motion on intensity modulated 
radiotherapy to the chest wall in patients with carcinoma breast and compare it with the 
respiratory motion effect on 3D conformal tangents based plan. 
Null Hypothesis:  
“The impact of respiratory motion on IMRT of the chest wall in post-mastectomy 
breast cancer patients is not significant compared to 3D conformal tangents.” 
Primary Objective:  
1. To determine the reduction in target coverage that can occur with respiratory 
motion when treated with IMRT and 3D CRT 
           2. To generate criteria for the selection of patients requiring post-mastectomy 
radiation for choosing techniques of delivering radiation therapy, on the basis of lung 
excursion data. 
Secondary Objectives: 
1. To see whether the lung and cardiac toxicity are under reported as compared to 
actual, when plans are calculated or evaluated on a free breathing CT scan 
3.2      DURATION AND DESIGN OF STUDY 
Duration: 12 months 
          November 2012 to October 2013 
- 24 - 
 
Design: Prospective trial 
3.3      SETTING 
Table 3.1:  Time line and setting 
Activity Location Timeline 
Recruitment of patients Radiotherapy Unit I OPD November 2012- October 2013 
Data collection Radiotherapy Department November 2012- October 2013 
 
3.4      PARTICIPANTS 
Inclusion criteria: 
1. Women with breast cancer who require post mastectomy radiotherapy to chest wall 
2. Patients who consent for undergoing 3 sets of CT scan in the same sitting and use of 
images for study purpose 
 
Exclusion criteria: 
1. Persons with restrictive/ obstructive lung disease  
2. Reconstruction flaps 
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3.5      METHODS 
 
 
  
YES 
NO 
Screening of patients with Carcinoma breast due 
for post- mastectomy radiotherapy 
Consent 
for study 
Patient Recruited 
Patient not recruited 
NO YES 
Base line respiratory parameters: 
 Respiratory rate at rest 
 Chest expansion 
 Spirometry and Lung volumes 
Satisfactory 
spirometry & 
lung volume 
evaluation 
 
Patient relieved from 
study 
Immobilisation on breast board 
Planning CT scan with RT markers 
 Slice thickness- 3 mm 
 Extent- C2 vertebra to adrenals 
 With IV Contrast 
 In free breathing 
2 more CT scan in the same position without 
correction for respiratory motion 
 Inspiratory breath hold (Crest 
images) 
 Expiratory breath hold (Trough 
images) 
 A 
A 
CT scan images are transferred to Treatment 
Planning System (TPS) – Eclipse 
Contouring is done on all 3 CT scans as per 
standard guidelines- 
 Target- Chest wall 
 Organs at risk- lungs, heart, 
contralateral breast 
PAGE 26 
YES 
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IMRT and 3D conformal tangent plans are generated on the CT scan done in free 
breathing and finalized by the same radiation oncologist 
 Prescription: 50 Gy in 25 fractions to CTV 
The IMRT and 3D conformal tangent plans finalized for the free breathing CT scan 
superimposed on the Crest and Trough images without changing the beam parameters 
Plan Evaluation: 
DVH of the 3 CT sets are compared 
(IMRT and 3D-CRT) 
 Target 
 Organs at risk 
 Lung 
 Heart 
 Opposite breast 
This process is repeated for all the 
recruited patients 
Generate a table of Tidal volume 
in litres and chest wall expansion 
in cm against Inspiration volume 
under dose and Expiration volume 
under dose 
Primary Objective: 
To determine the reduction in target coverage that can occur with respiratory 
motion when treated with IMRT and 3D CRT 
See whether criteria can be generated for the selection of a suitable technique 
of delivering post mastectomy radiotherapy on the basis of lung excursion 
data 
Secondary Objective: 
See whether lung toxicity is under reported as compared to actual when plans 
are finalized on free breathing CT scan. 
- 27 - 
 
Patients were recruited according to the above criteria and a written consent was 
obtained. Each study patient underwent the following procedures: 
As a baseline, a Spirometry and Lung volume study was done using the Jaegar’s 
Master Screen PFT, to assess the respiratory parameters of each patient recruited in to the 
trial. The parameters recorded were breathing frequency and tidal volume. They were also 
trained to hold their breath in inspiration and expiration for a minimum duration of 20 
seconds (the time taken to complete a CT thorax study). The Jaegar’s Master screen PFT 
was used to document the breath hold times of each patient.  
The second step was CT simulation of each patient in free breathing, inspiratory 
breath hold and expiratory breath hold. Rest of the study was dosimetric based, and patients 
were not required. 
Planning CT scan: 
The planning CT scans was carried out on PET CT Seimens Biograph which had a 
large bore size (convenient for breast board set up), flat couch and a speed capable of 
completing a CT thorax in 20 seconds. 
Each of the recruited patients were immobilised in supine position on a breast board 
with arms above the head using arm rests. The scar, chest wall borders, lower limit of 
contralateral breast were marked using angio-catheters. The 3 CT centers were marked with 
2mm lead balls on the body and along the same axial plane 2 mm lead balls were placed on 
the breast board on either side. The lead balls on the breast board were taken as the reference 
points to overlap inspiratory and expiratory CT scans, as these points don’t move with 
respiration. 80 ml of intravenous ionic contrast was administered and a free breathing CT 
scan of 3 mm slice thickness, FOV of 700 mm, extending from hyoid to adrenals was 
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captured. Subsequently, maintaining the above parameters a CT scan in inspiratory breath 
hold and another in expiratory breath hold were captured. The three image sets acquired for 
each patient were then transferred to the Varian Eclipse system. 
Contouring:  
The following structures were contoured as per guidelines on the free breathing CT 
scan, inspiratory breath hold CT scan and Expiratory breath hold CT scan 
a) Chest wall (CTV- Clinical Target Volume) as per RTOG guidelines (Appendix 2) 
b) Lymphnodal regions (CTV) as per RTOG guidelines (Appendix 2) 
c) Organs at risk: Lungs, Heart, Contralateral breast, Spine 
IMRT planning: 
The contouring and planning were done on IMRT Eclipse planning system (External 
beam planning v10.0.42; Varian Medical System, Palo, Alto, CA). 5-7 coplanar 6 MV 
photon beams were used (multileaf collimator width of 0.5 mm and dynamic IMRT) to 
generate the plan rendering a dose of 50 Gy in 25 fractions to target. Various dose 
constraints used for IMRT planning are shown in Table 3.2. 
Table 3.2: Dose constraints utilised in plan evaluation 
Organs Dose Constraints 
Unilateral Lung V20<=30% 
Combined Lungs V20 <20% 
Heart V25<10% 
Spine Dmax< 45Gy 
Contralateral breast Mean dose < 5% of prescribed 
Target V95 > 95% 
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3D Planning 
The CT imaging data used for IMRT planning was exported to PLATO RTS 
Version 2.7.7. No changes were made in the contoured structures. 4 Coplanar opposed 
tangential beams of 6/15 MV were used to generate a plan rendering 50 Gy in 25 fractions 
to target volume (chest wall) and separate adjacent fields were planned for lymphnodal 
CTV. 
Both plans were evaluated and approved by an independent radiation oncologist for 
all ten patients. 
Superimposition of Inspiratory and Expiratory images on IMRT and 3D-CRT plans 
The final and the most critical task was the superimposition of the Inspiratory and 
Expiratory images on the planned IMRT and 3D conformal therapy plans. The leaf 
sequence and the fields applied on the base plan were superimposed on the inspiratory and 
expiratory sets of images by matching the fiducials on the breast board. The isocentre of 
the plan may have shifted with reference to the body structures because of the respiratory 
motion. The dose calculation was run without any change in leaf sequences, field size, shape 
or angle. The isodose distribution and coverage were compared in the three sets of images 
for each patient.  
3.6      VARIABLES AND SCALES USED IN THIS STUDY 
 
Baseline Respiratory parameters: 
1. Respiratory rate at rest 
2. Amplitude of respiration / chest expansion 
3. Tidal volume in litres 
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Measurements of respiratory motion: 
1. Chest wall expansion –Patient’s chest wall circumference at normal inspiration and 
at normal expiration was measured. The difference between the 2 values was taken 
as chest wall expansion. These values for all the 10 patients were documented. 
Factors that affect set up uncertainties: 
1. Height 
2. Weight 
3. Body mass index 
Plan comparison parameters: 
1. Target dose coverage 
V90: Volume of target in percentage receiving dose above 90% of prescribed dose (45 Gy) 
 V95: Volume of target in percentage receiving dose above 95% of prescribed dose (47.5 
Gy) 
 V100: Volume of target in percentage receiving dose above 100% of prescribed dose (50 
Gy) 
 V107: Volume of target in percentage receiving dose above 107% of prescribed dose (53.5 
Gy) - represents hot spot 
 D95: Dose in Gy received by more than 95% of target volume (represented target coverage) 
 D98: Dose in Gy received by more than 98% of the target volume (represents the low dose) 
 D2: Dose in Gy received by less than 2% of the target volume (represents the high dose) 
2. Dose to organs at risk  
a.   Lung V20: Volume of the combined lungs receiving more than 20 Gy and V10: Volume 
of the lung receiving more than 10 Gy for ipsilateral and contra lateral lung 
- 31 - 
 
b.   Heart V25: Volume of Heart receiving more than 25 Gy 
c.   Opposite breast: mean dose received by opposite breast <5% of prescribed dose 
Table 3.3: Data sources and measurement 
SOURCE VARIABLES MEASURE 
Manual Respiratory rate Breaths/min 
Lung Volumes Tidal Volume Litres 
Measuring tape Chest wall movement Centimeters 
Scales Body mass index Kg/m2 
Dose volume histogram (DVH) 
 
 
Target dose coverage  CTV- V90,V95,V100 
          D95, D98, D2 
Dose to organs 
1. Lungs 
 
2. Heart 
3. Spine 
4. Opposite breast 
 
V20<20% (Combined lungs) 
V20<30% (ipsilateral lungs) 
V25<10%  
Maximum dose<45 Gy 
Mean dose<5% 
 
The above parameters were used to compare a conformal tangent plan versus an 
IMRT plan and assess the influence of respiration on both these techniques of radiation.  
3.7      OUTCOME 
To find the influence of respiration in IMRT versus 3D conformal plans, patients 
were categorised according their chest wall expansion as well as tidal volume (quartiles) 
and the mean target coverage and doses to organs at risk with inspiration and expiration in 
IMRT versus 3D conformal tangents were compared. 
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3.8      SAMPLE SIZE 
This study was undertaken to understand the variation with respiration in the volume 
of target organ receiving radiation with IMRT compared to that of 3D CRT (95% to 100% 
of the volume of target organ receiving 95% of prescribed dose was accepted).  Any 
reduction more than 5% from 95% is seen as significant reduction in the intended exposure. 
The following table shows if the sample size is 5, the standard error of the sampling 
distribution will be as high as 4.77(almost 5% which is not acceptable).  The proposed 
sample size of 10 will have a standard error of 2.89 versus 2.27 with a sample size of 15. 
Since there is only a small incremental improvement in the standard error with an increased 
sample size of 15 and as it was not feasible to complete the comparison between IMRT and 
3DCRT in more than 10 patients during the study period, we proposed to study 10 subjects  
 
Table 3.4: Effect of sample size on 95% 1-tailed confidence interval of volume of target 
organ receiving the radiation dose 
Proposed sample 
size 
SE 
Critical value for 
respective d.f 
1- sided 95% 
probability 
5 2.24 2.13 4.77 (90.23 - 95) 
10 1.58 1.83 2.89 (92.11 - 95) 
15 1.29 1.76 2.27 (92.73 - 95) 
20 1.2 1.729 2.07 (92.93 – 95) 
 
3.9      STATISTICAL ANALYSIS 
Baseline analyses included calculation of descriptive statistics such as mean, 
standard deviation and median and quartiles for all the dosimetric variables mentioned 
above. This was done for IMRT and 3D conformal tangents separately. 
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Then, comparison between the two groups of data (IMRT and 3D conformal 
tangents) was carried out by comparison of means. All differences between the 2 groups’ 
two-tailed alpha value less than 0.05 were considered significant. 
The outcome analyses included categorisation of the study patients according to the 
interquartile range calculated for chest wall expansion as well as tidal volume. Following 
which, a comparison of the means of all dosimetric variables between IMRT and 3D 
conformal tangents was executed.   
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4.    RESULTS AND ANALYSIS 
4.1      OVERVIEW OF PATIENTS RECRUITED IN THE STUDY 
Six of the sixteen patients recruited in the study received Intensity modulated 
radiotherapy, while the rest underwent treatment with 3D conformal radiotherapy. 
All the sixteen patients fulfilled the spirometric assessment done to ascertain 
whether they are able to hold their breath in inspiration/ expiration for the time duration of 
CT scan thorax (20 seconds).  
Table 4.1: Demographic and clinical characteristics 
Total number of patient screened 21 
Patients who were recruited in to the study 16 
Patients who underwent IMRT and 3DCRT 
planning and data was analysed 
10 
Patients not recruited 5 
Unable to hold breath for 20 seconds-3 
Not consented for study- 2 
Age (n=10) Mean age- 50.1 years 
Minimum age- 35 years 
Maximum age- 75 years 
Body Mass Index Mean BMI- 28.79 
No: of patients with normal  BMI- 2 
No: of patients Overweight- 5 
No: of patients Obese- 3 
Stage  Stage II- 7 
Stage III- 3 
Laterality Right- 6 
Left- 4 
Regions treated Chest wall only- 2 
Chest wall and supraclavicular region- 8 
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4.2      MAGNITUDE AND MEASUREMENT OF RESPIRATORY 
MOTION IN THE PATIENTS RECRUITED 
 
Table 4.2:  Magnitude of respiratory motion among the study population 
Respiratory motion 
Quantiles 
Variables n Mean SD Min 0.25 Median 0.75 Max 
Respiratory 
Rate 
10 20.3 4.11 15 18 20 22 30 
Tidal 
Volume 
10 0.66 0.16 0.44 0.49 0.68 0.8 0.85 
Chest wall 
movement 
10 0.67 0.28 0.50 0.50 0.50 1 1.2 
 
Respiratory rate of the 10 patients varied between 15/min to 30/min. The tidal 
volume varied between 0.44 to 0.85 litres with a median of 0.68 and the chest wall 
movement varied between 0.5 to 1.2 cms with a median of 0.5 cms. 
 
Figure 4.1: Bar graph depicting the distribution of the study population according to tidal 
volume. Bar 1 shows that there were 5 patients with a tidal volume of ≤0.68 L, Bar 2 
shows 5  patients with tidal volume  > 0.68 L 
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Figure 4.2: Bar graph depicting the distribution of the study population according to 
magnitude of chest wall movement. Bar 1 show that 7 of the 10 patients had a Chest wall 
movement of ≤ 0.5 cm and Bar2 shows 3 patients with Chest wall movement of ≥ 0.5 cm 
4.3      THE IMPACT OF RESPIRATORY MOTION ON INTENSITY 
MODULATED RADIOTHERAPY PLAN 
 
Target: Chest wall   Coverage (Table 4.3- 4.6) 
Table 4.3: Comparison of the V90 (Volume receiving 90% of prescribed dose) of chest 
wall at different phases of respiratory cycle for IMRT technique 
V90 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 98.9 0.52 98.0 98.525 98.85 99.35 99.6 
Normal 
Inspiration 
 
10 91.07 6.39 79.6 86.575 90.95 96.6 99.1 
Normal 
Expiration 
 
10 91.92 5.63 83.3 86.7 92.35 97.17 97.8 
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Table 4.4: Comparison of the V95 (Volume receiving 95% of prescribed dose) of chest 
wall at different phases of respiratory cycle for IMRT technique. 
V95 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 95.69 1.58 93.5 94.5 95.4 97.6 98 
Normal 
Inspiration 
 
10 86.33 8.09 72.3 81.7 86.45 93.2 96.5 
Normal 
Expiration 
 
10 86.38 7.23 75.2 81 87.65 92.3 94.6 
Table 4.5: Comparison of the V100 (Volume receiving 100% of prescribed dose) of 
chest wall at different phases of respiratory cycle for IMRT technique. 
V100 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 77.03 7.61 63.8 72.4 77.65 80.3 92.5 
Normal 
Inspiration 
 
10 67.58 13.15 48 62 64.25 75.7 90.1 
Normal 
Expiration 
 
10 67.3 7.95 53.5 61.2 68.1 72.6 80.5 
Table 4.6: Comparison of the D 95 (Dose in Gy received by 95% of volume) of chest wall 
at different phases of respiratory cycle for IMRT technique. 
 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 47.81 0.74 46.9 47.27 47.65 48.45 49.3 
Normal 
Inspiration 
 
10 41.47 6.3 28.1 37.7 43.0 46.47 47.3 
Normal 
Expiration 
 
10 43.63 6.7 26.5 42.0 46.45 47.12 48.8 
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Target coverage with IMRT met the criteria of V95> 95% in 6 out of 10 patients 
with a mean value of 95.69% and the minimum value being 93.5%. However, when the 
target coverage with respiration was analysed by the parameter of V90, V95, V100 and D95 
it was found that there was mean target under-coverage.  The magnitude of target under-
coverage was 9.39% and 9.31% with inspiration and expiration respectively in terms of 
V95. Similarly the mean target under coverage in terms of D95 with inspiration and 
expiration were 6.34 Gy and 4.18 Gy respectively. 
Hot spots (Tables 4.7 & 4.8) 
In all the 10 study patients it was possible to achieve a D2 of less than 110% in the 
free breathing CT scan. When the effect of respiration was analysed, it was found that the 
mean hot spot increased in the inspiratory and expiratory phases 8.01 Gy and 3.02 Gy 
respectively.  In one of the patients, D2 was as high as 71.2 Gy in inspiration. In terms of 
V107, the increase in mean hot spot was 19.37% and 11.68% with inspiration and 
expiration respectively. 
 
Table 4.7: Comparison of the V107 (Volume receiving 107% of prescribed dose) of 
chest wall at different phases of respiratory cycle for IMRT technique 
V107 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 3.03 5.94 0 0.1 0.7 1.9 19.0 
Normal 
Inspiration 
 
10 22.94 17.9 6.1 8.8 16.35 35 58.7 
Normal 
Expiration 
 
10 14.71 14.95 0.1 0.5 8.5 28.1 35.8 
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Table 4.8:Comparison of the D2 (Dose in Gy received by 2% of volume) which is also 
termed as “HOT SPOT” of chest wall at different phases of respiratory cycle for IMRT 
technique 
D2 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 53.14 0.81 52.2 52.6 53.1 53.4 54.8 
Normal 
Inspiration 
 
10 61.15 5.48 54.2 57.6 59.75 64.9 71.2 
Normal 
Expiration 
 
10 58.13 6.14 52.6 52.7 56.1 61.4 70.0 
 
Cold spot (Table 4.9): 
In 9 out of 10 study patients it was possible to achieve a D98 of at-least 90%. 
Comparison of D98 for IMRT technique revealed respiration resulted in cold spots within 
the target volume, mean of 31.68 to 36.28 Gy in inspiration and expiration respectively. 1 
of the patient’s D98 was as low as 4.3 Gy in inspiration and 14.6 Gy in expiration. 
Table 4.9: Comparison of the D98 (Dose received by 98% of volume) which is also 
termed as “Cold Spot” of chest wall at different phases of respiratory cycle for IMRT 
technique 
D98 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 44.6 4.45 32.2 45.3 45.75 46.4 47.5 
Normal 
Inspiration 
 
10 31.68 14.37 4.3 20.5 35.45 42.7 46.6 
Normal 
Expiration 
 
10 36.28 9.87 14.6 31.5 39.6 43.9 44.7 
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Organs at risk   
Lungs (Table 4.10): 
It was seen that change in mean ipsilateral lung volume receiving 20 Gy was 6.62% 
with inspiration and 4.27% with expiration. Similarly the change in mean combined lung 
volume receiving 20 Gy was 3.28% with inspiration and 1.83% with expiration. 
Table 4.10: Comparison of the mean dose delivered to ipsilateral lung, contralateral lung 
and combined Lungs at different phases of breathing cycle for IMRT technique. 
 V20 V10 
 FB NI NE FB NI NE 
Ipsilateral 
lung 
18.36 24.98 22.63 54.12 59.38 56.43 
Contralateral 
lung 
0 0 0.02 0.12 0.37 0.31 
Combined 
lungs 
9.53 12.81 11.36 27.94 30.57 29.27 
Abbreviations: Vx= percentage of volume receiving x% of prescribed dose; FB, NI, NE refer to 
respiratory phases of CT scan (free breathing, normal inspiration and normal expiration 
respectively) 
 
Heart (Table 4.11):  
Comparison of mean heart dose (V25) in free breathing, normal inspiration and 
expiration showed that variation was a maximum of 1.38%. One study patient had a 
calculated dose of 12.8% with inspiration (crossing the tolerance limit of 10%). 4 of the 
10 patients had left sided tumour and the mean cardiac volume receiving dose of 25 Gy 
of these patients in free breathing, normal inspiration and normal expiration was 5.37%, 
7.95% and 3.65% while that of patients with right sided tumour were 0.63%, 1.21% and 
1.15% respectively. 
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Table 4.11: Comparison of the V25 (Volume receiving 25% of prescribed dose) of heart 
at different phases of respiratory cycle for IMRT technique. 
 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 2.53 3.10 0 0 1.9 4.0 9.6 
Normal 
Inspiration 
 
10 3.91 4.7 0 0 2.25 7.0 12.8 
Normal 
Expiration 
 
10 2.15 2.72 0 0 0.3 4.8 6.3 
 
4.4     THE IMAPCT OF RESPIRATORY MOTION ON 3D 
CONFORMAL RADIOTHERAY PLAN 
 
Target- Chest wall:   Coverage (Tables 4.12-4.15): 
 
Table 4.12: Comparison of the V90 (Volume receiving 90% of prescribed dose) of chest 
wall at different phases of respiratory cycle for 3D conformal tangents  
V90 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 97.9 1.22 96.3 96.75 97.8 98.77 100 
Normal 
Inspiration 
 
10 95.14 5.9 79.7 93.75 96.35 99.32 100 
Normal 
Expiration 
 
10 93.84 6.8 78.7 90.55 96.25 98.35 100 
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Table 4.13:  Comparison of the V95 (Volume receiving 95% of prescribed dose) of chest 
wall at different phases of respiratory cycle for 3D tangents 
V95 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 94.16 1.83 92.2 92.4 93.85 95 98.2 
Normal 
Inspiration 
 
10 91.04 6.52 80.8 84.6 92.2 97.4 99.6 
Normal 
Expiration 
 
10 90.53 5.57 81.5 87.2 92.1 94.7 97.5 
 
 
Table 4.14: Comparison of the V100 (Volume receiving 100% of prescribed dose) of 
chest wall at different phases of respiratory cycle for 3D tangents. 
V100 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 65.75 9.45 50.6 54.5 69.55 73.3 74.2 
Normal 
Inspiration 
 
10 60.68 17.20 33.9 44.6 64.4 70.4 84.2 
Normal 
Expiration 
 
10 60.52 16.67 32.4 51.5 59.9 70.9 86 
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Table 4.15: Comparison of the D 95 (Dose received by 95% of volume) of chest wall at 
different phases of respiratory cycle for 3D conformal tangents. 
 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 36.87 12.3 7.7 28.22 41.2 46.52 48.1 
Normal 
Inspiration 
 
10 47.12 0.57 46.0 46.8 47.1 47.57 47.9 
Normal 
Expiration 
 
10 41.98 8.7 22.7 36.4 45.9 47.6 48.5 
 
The overall target coverage with 3D-CRT was less (V95 > 95% could be achieved 
in only 3 out of 10 patients.  The analysis of change in parameters such as V90, V95, V100 
and D95 with respiration revealed that there was target under-coverage. The mean target 
under-coverage in terms of V95 with inspiration and expiration were 3.12% and 3.63% 
respectively. 
Hot spots (Table 4.16& 4.17): 
Table 4.16: Comparison of the V107 (Volume receiving 107% of prescribed dose) of 
chest wall at different phases of respiratory cycle for 3D conformal tangents.  
V107 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 0.82 1.02 0 0.2 0.3 1.4 2.8 
Normal 
Inspiration 
 
10 2.87 4.01 0 0.4 1.4 1.8 9.9 
Normal 
Expiration 
 
10 2.92 3.64 0 0.2 2.35 3.7 12.2 
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Table 4.17: Comparison of the D2 (Dose in Gy received by 2% of volume) which is also 
termed as “HOT SPOT” of chest wall at different phases of respiratory cycle for 3D 
conformal tangents technique 
D2 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 53.7 0.4 52.6 52.7 53 53.2 53.9 
Normal 
Inspiration 
 
10 53.58 1.17 52.5 52.6 53.35 53.5 56.2 
Normal 
Expiration 
 
10 53.42 0.9 52.6 52.6 53.5 54.1 54.7 
 
It was possible to achieve hot spot of D2 < 107% in all the 10 patients. When the 
effect of respiration was analysed it was found that mean D2 hardly changed. In terms of 
V107 the increase of hot spot with inspiration and expiration was 2.87% and 2.92% 
respectively. 
Cold spot (Table 4.18): 
Table 4.18: Comparison of the D98 (Dose received by 98% of volume) which is also 
termed as “Cold Spot” of chest wall at different phases of respiratory cycle for 3D 
conformal tangents  
D98 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 44.63 1.91 41.9 42.8 44.8 46 47.6 
Normal 
Inspiration 
 
10 40.44 11.49 13.4 36.2 44.55 47 52.2 
Normal 
Expiration 
 
10 38.38 10.89 12.6 35.4 43.35 45.1 47.2 
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It was possible to achieve a D98 of 90% in only 3 out of 10 patients with 3D-CRT 
on the free breathing scan. Comparison of D98 with respiration resulted in increase in cold 
spots within the target volume. The mean D98 was 40.44 with inspiration and 38.38 with 
expiration. 1 of the patients D98 was quite low, 13.4 Gy in inspiration and 12.6 Gy in 
expiration.  
Organs at risk 
Lungs (Table 4.19): 
Table 4.19: Comparison of the mean dose delivered to Ipsilateral lung, Contralateral lung 
and Combined Lungs at different phases of breathing cycle for 3D conformal tangent 
technique. 
 V20 V10 
 FB NI NE FB NI NE 
Ipsilateral 
lung 
23.63 25.76 23.44 28.22 30.17 27.91 
Contralateral 
lung 
0 0 0 0 0.01 0 
Combined 
lungs 
11.91 13.12 11.77 14.17 15.35 13.97 
Abbreviations: Vx= percentage of volume receiving x% of prescribed dose; FB, NI, NE refer to 
respiratory phase of CT scan (free breathing, normal inspiration and normal expiration 
respectively) 
 
It was seen that change in mean lung volume receiving 20 Gy varied by 
approximately 2% with normal inspiration in ipsilateral lung and combined lungs. There 
was hardly any change with expiration. 
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Heart (Table 4.20) 
Table 4.20: Comparison of the V25 (Volume receiving 25% of prescribed dose) of heart 
at different phases of respiratory cycle for 3D conformal tangents technique. 
 Quantiles 
Variables n Mean S.D Minimum 0.25 Median 0.75 Maximum 
Free 
breathing 
 
10 3.95 5.74 0 0 0.1 8.8 
16.3 
 
Normal 
Inspiration 
 
10 4.6 6.93 0 0 0 9.1 17.8 
Normal 
Expiration 
 
10 4.16 6.14 0 0 0 9.5 17.0 
 
Heart dose variation with respiration in 3D conformal tangents was assessed by 
comparing mean V25 (volume receiving 25 Gy) of 10 patients in free breathing, normal 
inspiration and expiration. The mean heart dose was higher by 0.21% and 0.65% in 
expiratory and inspiratory phases respectively when compared to free breathing. 4 out of 
10 patients had left sided breast cancer and their mean cardiac volume receiving 25 Gy in 
free breathing, normal inspiration and normal expiration was 9.82%, 11.5% and 10.4% 
respectively while that in patients with right breast tumour was 0.03%, 0%, 0% 
respectively. 
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4.5    A COMPARISON BETWEEN THE IMPACT OF RESPIRATORY 
MOTION ON INTENSITY MODULATED RADIOTHERAPY PLAN 
VERSUS 3D CONFORMAL RADIOTHERAPY 
 
Target coverage (Tables 4.21, 4.22 and Figure 4.3): 
Table 4.21: The dose-volume relationships of Chest wall for each of the 10 study patients 
using the CT scans acquired during FB and end of NI and NE 
 
Pt 
No 
 
Technique 
V90 (%) V95(%) V100 (%) 
FB NI NE FB NI NE FB NI NE 
1 
3D Tangents 99.6 93.9 99.1 98.2 92.9 97.5 67.9 84.2 86 
IMRT 99.3 83.2 97 98 77 91 92.5 48 64.5 
2 
3D Tangents 96.6 99.1 97.6 92.4 98.1 96.2 73.3 55.5 78.8 
IMRT 98.9 96.5 85.8 94.6 94.7 76 79.6 90.1 59.4 
3 
3D Tangents 97.7 97.2 98.1 95.4 97.4 94.7 73.6 80.5 69.7 
IMRT 98.6 99.1 97 94.5 96.5 92.3 78 85.1 73.5 
4 
3D Tangents 100 100 100 95 91.6 93.4 54.5 44.6 51.5 
IMRT 99.5 87.7 89.1 97.6 82.1 84.4 81.1 63.4 67.3 
5 
3D Tangents 98.5 95.5 85.3 94.9 80.8 82.1 74.2 70.4 70.9 
IMRT 99.3 96.5 87 96.1 93.2 81 63.8 70.1 53.5 
6 
3D Tangents 97.9 100 95 93.8 99.6 87.2 52.2 67.3 32.4 
IMRT 98.3 96.9 95.6 95.3 92.9 90.8 75.1 63.3 68.9 
7 
3D Tangents 96.3 96.3 78.7 93.5 89.5 92.4 69.6 33.9 61.6 
IMRT 98.8 92.1 97.7 95.5 87.6 94 80.3 75.7 80.5 
8 
3D Tangents 98.2 79.7 92.3 93.9 83.1 81.5 72.1 61.5 58.2 
IMRT 98.8 89.3 88.9 94.2 81.7 84.5 72.4 62 72.6 
9 
3D Tangents 96.8 96.4 94.8 92.3 92.8 88.5 69.5 70.2 56.2 
IMRT 98 79.6 83.3 93.5 72.3 75.2 70.2 53 61.2 
10 
3D Tangents 97.4 93.3 97.5 92.2 84.6 91.8 50.6 38.7 39.8 
IMRT 99.6 89.8 97.8 97.6 85.3 94.6 77.3 65.1 72.5 
 
Table 4.21 shows the detailed dose volume information for the chest wall (V90, 
V95, V100). There was difference between the changes in chest wall coverage with 
respiration in IMRT versus 3D conformal tangents. However this difference is more 
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pronounced in some. The table shows that the study participants 1, 2, 4, 6 and 9 have a 
difference in chest wall coverage (under coverage) between IMRT and 3D conformal 
tangents of more than 5% in either inspiration or expiration. 
 
Table 4.22:  A comparison of means of between the target coverage (V95) for IMRT as 
well as 3D conformal tangent plans in free breathing versus normal inspiratory/ normal 
expiratory phases was carried out, to show whether the change in target coverage was 
significant with respiration 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference 
t- test 
Significance 
(2 tailed) 
lower upper 
V95 IMRT FB 
vs V95 IMRT NI 
9.36 2.67 3.31 15.4 3.5 0.007 
V95 IMRT FB 
vs V95 IMRT 
NE 
9.31 2.09 4.56 14.05 4.44 0.002 
V95 3D FB vs 
V95 3D NI 
3.12 2.11 -1.66 7.9 1.47 0.174 
V95 3D FB vs 
V95 3D NE 
3.63 1.71 -2.38 7.49 2.12 0.063 
 
Target coverage of mean V95 >95% was achieved with IMRT in free breathing CT 
scan while mean coverage was less than 95% (94.16%) with 3D-CRT. However, when a 
comparison of means for target coverage in terms of V95 for IMRT and 3D conformal 
tangents in free breathing versus inspiratory and expiratory phases was carried out, it was 
found that there was significant change in IMRT with respiration (0.007 and 0.002 
respectively) while the change was not significant in 3D conformal tangent plan (0.174 and 
0.063 respectively). 
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Figure 4.3: Line diagram showing the change in mean target coverage in terms of V95 
(volume receiving 95% of dose) with respiration in IMRT versus 3D conformal tangents. 
 
Figure 4.3 is a pictorial representation depicting the drop in target coverage of 
4.17- 4.71% in terms of V95 with IMRT when compared to 3D CRT. 
 
Hot spots (Table 4.23 and Figure 4.4): 
Though the mean hot spot with IMRT was similar to 3D-CRT (D2 of 53.14 and 53.7 Gy 
respectively), it was found that hot spots increases with respiration in IMRT plan when 
compared to 3D conformal tangent plan. However, it was not statistically significant. The 
line diagram also shows a trend favouring an increase in hot spots in IMRT with respiration 
of 11.79- 20.07% when compared to 3D conformal tangents.  
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Table 4.23:  A comparison of means of between the hot spots (V107) for IMRT and 3D 
conformal tangent plans in free breathing versus normal inspiratory/ normal expiratory 
phases was carried out, to show whether the change in hot spots was significant with 
respiration 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference 
t- test 
Significance 
(2 tailed) 
lower Upper 
V107 IMRT FB vs 
V107 IMRT NI 
-19.91 5.95 -33.38 -6.43 -3.34 0.09 
V107 IMRT FB vs 
V107 IMRT NE 
-11.68 5.47 -24.07 0.71 -2.13 0.062 
V107 TGT FB vs 
V107 TGT NI 
-1.98 1.3 -5.04 1.07 -1.4 0.172 
V107 TGT FB vs 
V107 TGT NE 
-2.1 1.11 -4.62 0.42 -1.88 0.092 
   
 
Figure 4.4: Line diagram showing the change in mean HOT SPOTS in terms of V107 
(volume receiving 107% of dose) with respiration in IMRT versus 3D conformal 
tangents. 
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Cold spots (Table 4.24 and Figure 4.5): 
 
Table 4.24: A comparison of means of between the cold spots (D98) for IMRT as well as 
3D conformal tangent plans in free breathing versus normal inspiratory/ normal 
expiratory phases was carried out, to show whether the change in cold spots was 
significant with respiration 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference 
t- test 
Significance 
(2 tailed) 
lower upper 
D98 IMRT FB vs 
D98 IMRT NI 
12.98 4.90 1.87 24.08 2.64 0.027 
D98 IMRT FB vs 
D98 IMRT NE 
8.38 3.19 1.14 15.61 2.61 0.028 
D98 TGT FB vs 
D98 TGT NI 
4.19 3.71 -4.20 12.58 1.12 0.288 
D98 TGT FB vs 
D98 TGT NE 
5.81 3.56 -2.25 13.87 1.63 0.138 
 
 
Figure 4.5: Line diagram showing the change in mean COLD SPOTS in terms of D98 
(dose received by 98% of volume) with respiration in IMRT versus 3D conformal 
tangents. 
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The mean minimum dose received by target was similar in IMRT and 3D-CRT 
(44.6% and 44.63% respectively). However, when the significance of the increase in cold 
spots with respiration was checked, it was found that magnitude of cold spots occurring 
in IMRT with respiration was significant while that with 3D CRT was not. 
The line diagram is a pictorial representation which also shows that there is a 
definite increase in cold spots with IMRT when compared to 3D conformal tangents. The 
mean D98 of IMRT with inspiration was less than 3D tangents by 12.95 Gy and with 
expiration by 4.16 Gy.  
 
Organs at risk 
Ipsilateral Lung (Table 4.25 and Figure 4.6): 
It was seen that change in volume of lung receiving 20 Gy occurring with 
respiration is significant only in inspiration for an IMRT plan. There seems to be no 
significant change in expiration for IMRT plan. The effect of respiration on 3D 
conformal tangents in terms of ipsilateral lung dose is insignificant. 
A comparison of the lung dose variation in each patient that occurs with 
respiration showed that it was more with IMRT than 3D conformal tangents, except in 1. 
This is depicted in Figure 4.6.  A trend line was generated to clarify this finding and it 
supported the fact that variation in lung dose with respiration in IMRT was more than 3D 
CRT.  
 
- 53 - 
 
Table 4.25:  A comparison of means of between the ipsilateral lung dose (V20) for 
IMRT as well as 3D conformal tangent plans in free breathing versus normal inspiratory/ 
normal expiratory phases was carried out, to show whether the change was significant 
with respiration 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference 
t- test 
Significance 
(2 tailed) 
lower upper 
V20 IMRT FB vs 
V20 IMRT NI 
-6.62 1.37 -9.72 -3.51 -4.82 0.001 
V20 IMRT FB vs 
V20 IMRT NE 
-3.98 1.93 -8.35 0.39 -2.05 0.07 
V20 TGT FB vs 
V20TGT NI 
-2.13 2.39 -7.55 3.29 -0.88 0.397 
V20 TGT FB vs 
V20 TGT NE 
0.19 1.85 -4.00 4.38 0.102 0.921 
 
 
Figure 4.6: Line diagram showing variation of the ipsilateral lung volume receiving 20 
Gy with respiration in IMRT and 3D conformal tangents in each of the 10 study 
participants. 
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Combined lungs (Table 4.26 and Figure 4.7): 
The change in volume of both lungs receiving 20 Gy occurring with respiration was 
significant only in inspiration for an IMRT plan. There seems to be no significant change 
in expiration for IMRT plan. The effect of respiration on 3D conformal tangents in terms 
of combined lung dose is insignificant. 
 
Table 4.26: A comparison of means of between the combined lung dose (V20) for IMRT 
as well as 3D conformal tangent plans in free breathing versus normal inspiratory/ normal 
expiratory phases was carried out, to show whether the change was significant with 
respiration 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference t-test 
Significance 
(2 tailed) 
lower upper 
V20 IMRT FB vs 
V20 IMRT NI 
-3.28 0.66 -4.79 -1.76 -4.90 0.001 
V20 IMRT FB vs 
V20 IMRT NE 
-1.83 0.93 -3.94 0.28 -1.95 0.082 
V20 TGT FB vs 
V20 TGT NI 
-1.21 1.39 -4.37 1.95 -0.865 0.409 
V20 TGT FB vs 
V20 TGT NE 
0.14 1.10 -2.35 2.63 0.127 0.902 
 
A comparison of the variation with respiration showed that it was more with IMRT 
than 3D conformal tangents, except in 1 patient. This is depicted in Figure 4.7. It also shows 
the trend in variation which also supports the same fact in terms of V20 of combined lung.  
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Figure 4.7: Line diagram showing variation of the combined lung volume receiving 20 
Gy with respiration in IMRT and 3D conformal tangents in each of the 10 study 
participants. 
 
Heart (Table 4.27 and Figure 4.8): 
 
Comparing the dose received by heart in left sided breast cancer patients, it was 
found that the mean cardiac dose was higher with 3D-CRT when compared to IMRT 
(5.37% vs 9.82%). At the same time, the change in volume of heart receiving 25 Gy 
occurring with respiration was not significant in either IMRT or 3D conformal tangents. 
However, the mean percentage volume of heart receiving 25 Gy in 3D-CRT crossed 10% 
in left sided radiation therapy plans. 
Comparison of heart doses in IMRT versus 3D conformal tangents showed that 
the variation with respiration was more with IMRT than 3D conformal tangents. This is 
depicted in Figure 4.8. It also showed the trend in variation which supports the fact that 
effect of respiration on IMRT is more than that on 3D conformal tangents in terms of 
V25 of heart. 
0
5
10
15
20
1 2 3 4 5 6 7 8 9 10
V
ar
ia
ti
o
n
 o
f 
lu
n
g 
V
o
lu
m
e 
w
it
h
 
re
sp
ir
at
io
n
 in
 %
Study participants
Combined lungs V20 
IMRT Var
TGT Var
Trend (IMRT Var)
Trend (TGT Var)
3D 
3D  
- 56 - 
 
Table 4.27: Comparison of means- Volume of Heart receiving 25 Gy (V25) for IMRT in 
free breathing versus normal inspiration/ normal expiration as well comparison of 
Volume of heart  receiving 25 Gy (V25) for 3D conformal Tangents in free breathing 
versus normal inspiration/ expiration. 
 
Paired differences   
Mean SE 
95% confidence 
interval of the 
difference 
t-test 
Significance 
(2 tailed) 
lower upper 
V25 IMRT FB vs 
V25 IMRT NI 
-1.38 0.64 -2.84 0.08 -2.13 0.061 
V25 IMRT FB vs 
V25 IMRT NE 
0.38 0.82 -1.48 2.24 0.46 0.656 
V25 TGT FB vs 
V25 TGT NI 
-0.65 0.61 -2.03 0.73 -1.05 0.318 
V25 TGT FB vs 
V25 TGT NE 
-0.21 0.17 -0.60 0.18 -1.19 0.263 
 
 
Figure 4.8: Line diagram showing variation of Heart receiving 25 Gy with respiration in 
IMRT and 3D conformal tangents in each of the 10 study participants. 
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Contralateral breast 
Table 4.28: Comparison of the mean dose in percentage delivered to contra-lateral breast 
at different phases of breathing cycle for IMRT versus 3D conformal tangent technique. 
 FB NI NE 
IMRT 3.38 4.16 4.01 
3D Tangents 1.56 1.52 1.37 
 
The table 4.28 clearly shows that the overall dose to contralateral breast is higher 
with IMRT plan when compared to 3D CRT. However, it does not vary with respiration. 
Integral dose: 
The table 4.29 shows that the mean integral dose is higher with IMRT than 3D CRT. 
However there is no change in integral dose with respiration in either technique of 
radiotherapy. 
Table 4.29: Comparison of the volume of Body receiving 2%, 5% or 10% of the 
prescribed dose at different phases of breathing cycle with IMRT technique and 3D CRT. 
 
FB NI NE 
IMRT 3D IMRT 3D IMRT 3D 
 
Body 2% 
 
Body 5% 
 
Body 10% 
 
 
59.18 
 
41.78 
 
29.59 
 
 
28.9 
 
17.63 
 
13.23 
 
62.26 
 
43.39 
 
30.56 
 
29.1 
 
17.68 
 
13.3 
 
61.89 
 
44.45 
 
30.56 
 
28.7 
 
16.99 
 
12.86 
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4.6  CORRELATION BETWEEN THE MAGNITUDE OF 
RESPIRATORY MOTION AND ITS EFFECT ON THE 
RADIOTHERAPY TECHNIQUES 
 
Target coverage with Tidal volume: 
 
 
Figure 4.9: The 10 study patients were categorised according to their tidal volume 
(Category 1- TV ≤ 0.68L, Category 2- TV>0.68L) and their mean target coverage in 
terms of V95 with inspiration and expiration were used to compare between IMRT and 
3D CRT. 
 
It was found that the mean target coverage with inspiration and expiration in IMRT 
and 3D CRT plan were similar in patients with a tidal volume less than or equal to 0.68 L 
(the median tidal volume of the 10 patients). However in patients with a tidal volume of 
more than 0.68 L, there was a difference in the mean under coverage of target between 3D 
and IMRT of 11.2% in inspiration and 5.08% in expiration, though not statistically 
significant.  
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Dose received by organs at risk and Tidal volume 
The dose received by organs at risk was similar in both the Categories of tidal 
volume≤ 0.68L and >0.68 L in IMRT and 3D-CRT.
 
 
Figure 4.10 a &b: The 10 study patients were categorised according to their tidal volume 
(Category 1- TV ≤ 0.68 L, Category 2- TV>0.68 L) and their lung and heart volumes in 
terms of V20 and V25 respectively with inspiration and expiration were compared 
between IMRT and 3D CRT. 
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Target Coverage with Chest wall expansion 
 
Figure 4.11: The 10 study patients were categorised according to their chest wall 
expansion (Category 1- Expansion ≤ 0.5cms, Category 2- Expansion>0.5 cms) and their 
mean target coverage in terms of V95 with inspiration and expiration were used to 
compare between IMRT and 3D CRT. 
 
Analysis of mean target coverage when patients were divided according to chest 
wall expansion (Category 1: no. of patients was 7 and Category 2: no. of patients was 3) 
revealed that the difference between the coverage with 3D CRT and IMRT was 3.37 and 
5.17% respectively among patients in Category 1 (IMRT coverage being less than 3D CRT) 
while the difference in coverage in Category 2 was 1.77 and 7.8% respectively (IMRT 
coverage being less than 3D CRT). This difference was not statistically significant. 
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Dose received by organs at risk and Chest wall expansion 
Though the dose received by organs at risk did not change much with chest wall 
expansion, it was noticed that comparatively the heart dose with 3D CRT technique was 
more when chest wall expansion was more than 0.5 cms 
 
 
Figure 4.12 a&b: The 10 study patients were categorised according to their chest wall 
expansion (Category 1- Expansion ≤ 0.5 cms, Category 2- Expansion > 0.5 cms) and 
their lung and heart volumes in terms of V20 and V25 respectively with inspiration and 
expiration were used to compare between IMRT and 3D CRT. 
13.1 12.113.85 11.411.55 10.912.4 10.1
0
10
20
30
40
50
60
70
80
90
100
Expansion ≤ 0.5 cms Expansion > 0.5 cms
V
o
lu
m
e 
o
f 
C
o
m
b
in
ed
 lu
n
gs
 r
ec
e
iv
in
g 
 
2
0
 G
y
Category 1 Category 2
Combined lungs
IMRT NI
3D NI
IMRT NE
3D NE
3.11 5.73.4
7.2
1.6 3.32.8
7.1
0
10
20
30
40
50
60
70
80
90
100
Expansion ≤ 0.5 cms Expansion > 0.5 cms
V
o
lu
m
e 
o
f 
H
ea
rt
 r
ec
e
iv
in
g 
 2
5
 G
y
Category 1 Category 2
Heart
IMRT NI
3D NI
IMRT NE
3D NE
(A) 
(B) 
- 62 - 
 
4.7  COMPARISON BETWEEN IMRT AND 3D-CRT: TARGET 
DOSE WASH (V95) IN A PATIENT WITH TIDAL VOLUME > 0.68 L 
IN FREE BREATHING, NORMAL INSPIRATION AND NORMAL 
EXPIRATION 
 
  
Figure 4.13 a&b:  Shows the 95% isodose colour wash in axial and sagittal section at 
the level of carina and head of humerus respectively on Free breathing CT scan with 
IMRT plan 
  
Figure 4.14 a&b: Shows the 95% isodose colour wash in axial and sagittal section at the 
level of carina and head of humerus respectively on Normal Inspiration CT scan with 
IMRT plan 
(A) (B) 
(A) (B) 
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Figure 4.15 a&b: Shows the 95% isodose colour wash in axial and sagittal section at the 
level of carina and head of humerus respectively on Normal Expiration CT scan with 
IMRT 
The above figures 4.13- 4.15 show the 95% isodose colour wash covering the target. 
As seen, the coverage is good in the Free breathing CT scan. However, in the normal 
inspiration CT scan, the areas of cold spots can be noticed. The cold spots were 
predominantly in the anterior and superior portions of the target volume. There were some 
areas of cold spots in the normal expiration CT scan as well.  
The spillage of the 95% isodose colour wash into the ipsilateral lung can also be 
visualised in the normal inspiration CT scan. However, the heart is spared. 
  
(A) (B) 
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Figure 4.16 a&b:  Shows the 95% isodose colour wash in axial and sagittal section at 
the level of carina and head of humerus respectively on Free breathing CT scan with 
3D-CRT plan 
  
Figure 4.17 a&b:  Shows the 95% isodose colour wash in axial and sagittal section at 
the level of carina and head of humerus respectively on Normal inspiration CT scan 
with 3D-CRT plan 
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Figure 4.18 a&b:  Shows the 95% isodose colour wash in axial and sagittal section at 
the level of carina and head of humerus respectively on Normal Expiration CT scan 
with    3D-CRT plan 
The 3D-CRT plan images are of the same patient as that of the IMRT plan images 
were taken and it showed that though there were few areas of cold spots in the normal 
inspiration and expiration images, it was not as clear as that seen with IMRT. 
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4.8 COMPARISON OF DVH BANDS GENERATED FOR A PATIENT 
WITH TIDAL VOLUME MORE THAN 0.68L VERSUS A PATIENT 
WITH TIDAL VOLUME LESS THAN 0.68 L 
 
 
 
Figure 4.19 a&b:  Shows the DVH band of target coverage (red), combined lungs 
(yellow) and heart (green). Figure 4.19 a (patient with TV> 0.68) shows a wider DVH 
band for target coverage and combined lungs when compared to Figure 4.19 b (patient 
with TV <0.68)  
(B) 
(A) 
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5.      DISCUSSION 
The benefit of inversed planned IMRT over 3D tangential therapy and forward 
planned IMRT has been studied extensively in whole breast radiotherapy(23,24,26,41–51). 
However literature on post-mastectomy IMRT is scarce. As we all know, there is definite 
geometric difference between chest wall and whole breast, and these differences distinctly 
affect the dose distributions. It is further complicated by the errors in thoracic radiotherapy 
which consists of both set up error as well as error due to respiratory motion. The effect of 
respiratory motion has been studied in whole breast treatments but its effect on chest wall 
radiotherapy is poorly understood(34,52–61). 
 According to our knowledge, this is the first study which has comprehensively 
evaluated the dose to target as well as organs at risk and its changes with respiration in both 
IMRT and 3D conformal tangential therapy in post-mastectomy breast cancer radiation.  
All the patients recruited for the study were trained to hold their breath in inspiration 
and expiration for the duration of planning CT scan of Thorax. Contouring of target and 
organs at risk in all 3 image sets (free breathing, normal inspiration and expiration) was 
carried out according to established standards. The IMRT and 3D planning was done for 
each patient and it was time consuming. Planning of all the patients recruited could not be 
completed at the time of this report and therefore only 10 patient’s data was analysed. 
5.1   MAGNITUDE AND MEASUREMENT OF RESPIRATORY 
MOTION IN THE PATIENTS RECRUITED 
The magnitude of respiratory motion differs considerably between patients. We 
found that the respiratory rate differed between 15 breaths/ minute to 30 breaths/minutes 
among the 10 patients analysed (Table 4.2). The chest wall expansion varied between 0.5 
to 1.2 cms with a median of 0.5 cms and 75% quartile of 1 cm.  3 out of 10 patients had a 
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chest wall expansion of more than 1 cm (Figures 4.1 and 4.2). Korreman et al used RPM 
(Varian Real time Respiratory Position Management) system to show the mean chest wall 
excursion and found that at free breathing, the mean antero-posterior chest wall movement 
was 2.5 mm(52). Similary, Pederson et al also studied the antero-posterior excursion of 
chest wall in free breathing and found it to be 2.5 mm(53). Both these studies were done 
on patients with conserved breasts. They found that the mean heart dose could be reduced 
by using inspiratory gating or deep inspiratory breath-hold technique. 
 In the absence of respiratory management techniques which is propagated in the 
use of IMRT for breast cancer, we proposed this study to evaluate the correlation between 
the respiratory parameters and the target. Our study found that the mean tidal volume varied 
between 0.44 to 0.85 litres with a median of 0.68 L. 5 out of the 10 patients had a tidal 
volume of over 0.68 L. These are the patients who can be thought of as those with higher 
likelihood of changes with respiration. Peters et al has also documented that the lung 
volume changes by 10-25% with normal respiration.  
5.2      THE IMPACT OF RESPIRATORY MOTION ON INTENSITY 
MODULATED RADIOTHERAPY PLAN 
Target: 
This study demonstrated that there is definite under coverage of target in inspiration 
and expiration with IMRT plan (Tables 4.3-4.6).  Its magnitude was more than 5% in all 
the parameters assessed V90, V95, V100 and D95, reaching 10% variation in the parameter 
V95. A target under coverage of more than 5% in a clinical setting is significant. Even 
though it may be argued that the patient is not constantly in a respiratory phase in which 
target under dosage will occur, the fact is free breathing CT scan does not give the exact 
picture of target coverage or dose to organs at risk. 
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Keall et al has proven dosimetrically that respiratory motion causes considerable 
issue for IMRT delivery as beam intensity gradient is not confined solely to edges of the 
beams. Target while moves within this field in its own velocity different from that of the 
MLC leaves as well as deformation during its movement adversely affects the target 
coverage(35). Phantom studies which evaluated the effect of respiratory motion on target 
coverage with IMRT showed that difference in target doses between stationary and moving 
phantom ranged between -18.8% to 19.7%. Due to their random nature it was concluded 
that errors will average out during fractionated treatment and that IMRT treatments can be 
employed in targets which move with respiration(61). However, the point to be noted is 
that stationary phantom or moving phantom can’t be equalled to a patient whose breathing 
pattern is not regular. 
Analysing the magnitude of hot spots we found that it crossed the limit of 10% in 
both inspiratory CT images as well as expiratory CT images (Tables 4.7 & 4.8). Hot spot 
of more than 10% in IMRT technique is significant and not acceptable. Especially in the 
setting of chest wall irradiation, where the hot spot may fall on organs at risk such as lungs, 
heart or brachial plexus (if nodal regions are being irradiated). This cannot be corrected by 
on board imaging and correction would require target tracking, which also is not likely to 
give 100% accuracy. 
The magnitude of cold spots in an IMRT plan was assessed by the parameter D98 
of target volume (dose received by 98% of target volume). Comparison of the D98 of target 
in the 2 phases of breathing (inspiration and expiration) with the free breathing CT scan 
showed that respiration results in production of cold spots within the target. The mean D98 
in inspiration was less by 28.9% of the planned dose (Table 4.9). 
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Organs at risk: 
The variation in dose received by organs at risk with respiration in post-mastectomy 
setting was analysed (Table 4.10). It was found that there was minimal change in mean 
combined lung volume receiving 20 Gy with respiration (1.21%) 
Rudat et al compared tangential beam IMRT versus tangential 3D- CRT, Koshy et 
al tried a novel technique such as non- coplanar intensity modulated radiotherapy and 
Cavey et al analysed conventional versus forward planned IMRT (1,62,63) to spare normal 
tissue. From these studies it was concluded that IMRT results in increased conformity index 
in the target with sparing of lungs and heart especially in left sided breast irradiation. 
However, George et al showed in whole breast treatments that lung and heart doses 
increases with respiratory motion(60). Increase in dose to organs at risk with respiration 
was seen in this study as well, but it did not cross the tolerance limits (V20 < 20% for 
combined lung and V20 < 30% for ipsilateral lung).  
We analysed the cardiac dose variation with respiration in the 10 study patients and 
found that mean heart volume (V25) receiving 25 Gy in free breathing, normal inspiration 
and expiration was as low as 2.53%, 3.91% and 2.15% respectively. They did not cross the 
tolerance limit of 10% with respiration (Table 4.11).  However, in 1 of the 10 patients this 
criteria was not satisfied and the V25 was 12.8%. 4 of the 10 patients had left sided tumour, 
the mean cardiac dose of these patients in free breathing, normal inspiration and expiration 
was 5.37%, 7.95% and 3.65%. These means were also within the tolerance limit. 
Ischemic heart disease, a late adverse effect of breast cancer irradiation has been 
evaluated at length and found to correlate with radiation dose. Though various methods of 
reducing the heart dose are available such as use of Non coplanar IMRT, we know that 
dose changes with respiration(26,28,54,59,62,64–66). A clinical trial by Tezcanli et al 
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analysed the cardiac dose variation with respiration in patients receiving IMRT for breast 
cancer (post breast conservation surgery or post mastectomy) and found that though the 
difference for whole heart, right and left ventricles, right and left atria, LAD+5 mm were 
not significant, the mean heart dose did cross the tolerance dose with inspiration in some 
patients (3 out of 10 patients). They concluded that radiotherapy planning for left sided 
breast cancer patient without breath control technique is not capable of compensating for 
whole intra fraction heart and its components’ volumes and dose changes (67). 
In this study the dose received by contralateral breast was higher with IMRT plan 
but it was limited to a tolerance dose of <5% of prescribed dose.  Inspiration and expiration 
did not affect the dose received by contralateral breast. Van der Laan et al and others have 
also shown that the contralateral breast dose is higher with IMRT when compared to 3D-
CRT(68).  
We documented that dose received by non-target tissue by the parameter V2%, 
V5% and V10% of the total body volume and found that it was as high as 59.18%, 41.78% 
and 29.59% in free breathing, normal inspiration and normal expiration respectively.  Study 
done by Palm and Johansson et al compared the out of field dose with conventional, IMRT 
and proton therapy and found that though IMRT results in increased dose to target tissue 
and reduced dose to nearby normal tissue, it also resulted in increased out of field dose and 
irradiated non-target volume(69).  
5.3   THE IMPACT OF RESPIRATORY MOTION ON 3D 
CONFROMAL TANGENT RADIOTHERAPY PLAN 
Respiratory motion affects all techniques of post- mastectomy radiotherapy but its 
magnitude changes with the technique. The need for normal tissue sparing has become of 
extreme importance with the growing use of chemotherapy. Thus, it is thought that 
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technologies which are capable of delivering high dose to tumour while sparing healthy 
tissue will balance the complication and cure rates. While advocating for respiratory 
motion management techniques in breast cancer radiotherapy, it is important to remember 
that these techniques are neither patient nor treatment team friendly. Thus it is not an easy 
solution to respiratory motion induced errors of radiotherapy(35). 
It is also important to be aware that respiratory motion is just one potential source 
of error in radiotherapy. Smith et al showed that the magnitude of error caused by 
respiratory motion is less than that induced by set up issues(34). However, to ensure target 
coverage a large PTV margin should be given. Thus, during 3D planning of chest wall 
radiotherapy the MLCs are kept at-least 1 cm away from the skin and 0.5 cm into the lung. 
This increased treatment volume increases the likelihood of treatment related 
complications. At the same time, if margins are not adequate part of the CTV will not get 
covered. Since, all patients are given the same PTV margin it can be postulated that target 
under coverage is likely to happen in those with larger chest wall movement during 
respiration. 
As the 3D treatment duration of 40 seconds consists of 14 breaths per fraction, it is 
postulated that the intra-fraction organ motion causes an averaging or blurring of dose 
distribution over the path of motion. This results in the deviation between intended and 
delivered dose distribution. Since in non IMRT treatments the dose gradient in the centre 
of the field is small, the blurring of dose distribution occurs only at the edge of the field 
thereby increasing penumbra(35). Thus target under coverage is likely to occur only at the 
beam edges in case of 3D treatment. 
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Target: 
In this study we see that the overall target coverage with 3D conformal tangent 
technique was less than IMRT. Respiration also added to target under-coverage. Opp et al 
has also studied target coverage in various techniques of post- mastectomy radiotherapy 
and concluded that IMRT and Bolus electron conformal therapy had the best target 
coverage and least heart dose when compared to field in field or tangential 
radiotherapy(70).  
Target coverage in various phases of respiration for 3D conformal tangents 
technique was analysed by comparing parameters such as V90, V95, V100 and D95 
(Tables 4.12-4.15). It was found that there was mild under-coverage of target volume with 
respiration. The mean target under-coverage in terms of V95 with inspiration and 
expiration were 3.12% and 3.63% respectively. 
Evaluating the magnitude of variation of hot spots with respiration, it was found 
that there was minimal/ no increase in hot spot (Tables 4.16 & 4.17).  
There was an increase in cold spots within the target with respiration in 3D-CRT 
plans as well. However, the magnitude was less when compared to IMRT. The cold spot 
within the target was reduced by 14% with respiration (Table 4.18). 
Organs at risk: 
Documentation of the doses received by organs at risk in different phases of 
respiratory motion in 3D CRT plan was important to finally compare the effect of 
respiratory motion on the 2 techniques of radiation. 
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Our study (Table 4.19) showed that there was only a minimal increase in the volume 
of lungs receiving 20 Gy with normal inspiration and expiration. However it didn’t cross 
the tolerance limits (V20 <20% for combined lungs and V20<30% for ipsilateral lung). 
Similarly, there was only minimal variation of Heart dose with respiration (Table 
4.20).  Sub analysis of the 4 patients who had left sided radiotherapy showed that the 
cardiac dose was higher than IMRT and the mean cardiac dose crossed the limit of 10% 
with respiration.  
Dose to contralateral breast with 3D conformal tangent technique was low and had 
no significant variation with respiration (range 1.37 to 1.56%), Table 4.28. 
Integral dose was low and did not change with respiration (Table 4.29). 
5.4   A COMPARISON BETWEEN THE IMPACT OF RESPIRATORY 
MOTION ON INTENSITY MODULATED RADIOTHERAPY PLAN 
VERSUS 3D CONFORMAL RADIOTHERAPY  
 
There is no gold standard technique for the delivery of radiation for breast cancers, 
especially in post-mastectomy setting. The ideal radiotherapy plan for each patient differs 
according the patient anatomy and the regions that need to be treated. The main advantage 
of IMRT over 3D conformal tangent quoted in literature is the sparing of organs at risk and 
the improved conformity index, specifically when nodal regions need to be treated(1). Al- 
Rahbi et al did a dosimetric comparison between 3D CRT, forward planned IMRT and 
inverse planned IMRT (10 out of 20 patients evaluated were post- mastectomy). He 
concluded that all 3 techniques achieved comparable target coverage, inverse planned 
IMRT had better conformity index at the cost of homogeneity(71).  These advantages were 
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clearly seen even in our study as well. However, the magnitude of impact of respiratory 
motion on IMRT and 3D CRT for chest wall needed to be evaluated. 
Target: 
Table 4.22 shows that when a bivariate analysis is done to compare 2 means, the 
difference in target under-coverage with normal inspiration and normal expiration are 
significant in an IMRT plan while that in 3D conformal tangents plan is not significant. 
This target under coverage is well depicted in Figure 4.3. 
From Table 4.23 we can conclude that the increase in hot spots with inspiration in 
IMRT plan was significant while that with 3D conformal tangents was not. This increase 
in hot spots in IMRT plan is depicted clearly in Figure 4.4. 
Table 4.24 showed that there was significant increase in cold spots in IMRT plan 
with inspiratory and expiratory phases while that with 3D conformal tangents was not 
significant. Figure 4.5 shows the difference in cold spots with respiration in IMRT versus 
3D-CRT, favouring the latter. 
Organs at risk: 
In 8 out of the 10 study patients, lung dose with 3D CRT was more than that of 
IMRT.  Similarly with the heart dose, 8 out of 10 patients had better whole heart sparing 
with IMRT than 3D CRT.  However, the evaluation of the effect of respiratory motion on 
the dose to organs at risk needed comparison. 
From Tables 4.25 and 4.26 we can conclude that increase in lung dose with 
respiration was significant with IMRT while that with 3D conformal tangents was not. 
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Table 4.27 showed that the increase in heart dose with respiration in IMRT and 3D 
conformal tangents are not significant. However, the volume of heart receiving 25 Gy 
crossed the limit of 10% with 3D-CRT in left sided tumour. Hence, it can be concluded 
that heart sparing is better with IMRT even in the presence of error caused by respiratory 
motion. 
It was seen that the mean contralateral breast dose was higher with IMRT than 3D 
CRT. However, it did not change with respiration (Table 4.28).  
This study also shows that integral dose is higher with IMRT than 3D CRT, though 
there was no change with respiration (Table 4.29). 
Comparison of the duration of treatment with IMRT and 3D-CRT 
IMRT treatment of chest wall takes 8 minutes while 3D CRT treatment of chest 
wall is completed in 40 seconds (beam on time). The mean respiratory rate of the 10 
patients studied was 20.3 breaths/ minute. The predicted number of breathing cycles per 
treatment fraction will be 162 with IMRT and 14 with 3D conformal therapy. Thus we can 
infer that even small changes in target coverage and dose to organs at risk with respiration 
can adversely affect an IMRT plan when compared to a 3D CRT plan. The duration of 
beam on time is more with hypofractionated radiotherapy and hence this effect may be 
more pronounced  if we use  treatment regimens such as 4005 cGy in 15 fractions proposed 
by UK START trial(72) or the proposed 5 fraction regimen by FAST FORWARD trial(73) 
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5.5 CORRELATION BETWEEN THE MAGNITUDE OF 
RESPIRATORY MOTION AND ITS EFFECT ON RADIATION 
THERAPY TECHNIQUES  
This study clearly demonstrates that there is definite under coverage with 
respiration in both techniques of post-mastectomy radiotherapy (IMRT and 3D CRT). The 
effect of respiratory motion on IMRT was more than that on 3D CRT plans. However, we 
wanted to further qualify this finding on the basis of patient’s tidal volume (TV) and chest 
wall movement. The reason behind this was, our knowledge from literature shows that 
larger chest wall movement causes greater target under dosage and over dosage of organs 
at risk.  We also did not want to totally negate the benefits of IMRT over 3D CRT in terms 
of organ sparing and dose homogeneity especially in patients who require nodal irradiation. 
Thus, by categorising the 10 study patients according to their tidal volume 
(Category 1- TV ≤ 0.68L and Category 2- TV >0.68L, where 0.68 L was the median value 
of the 10 patients), we found that the effect of respiratory motion on IMRT plan was more 
in patients belonging to Category 2 (Figure 4.9). Because of the small sample size only a 
trend could be shown and significance of this finding could not be ascertained. 
Similarly, the 10 study patients were also categorised according to their chest wall 
movement (Category 1- Expansion ≤ 0.5 cm, Category 2- Expansion > 0.5 cm, where 0.5 
cm was the median value of the 10 patients). We found that there was a trend favouring 3D 
CRT plan when a patient’s expansion on larger than 0.5 cm (Figure 4.11).  
DVH bands seen in Figure 4.19 (the cumulative DVHs in free breathing, normal 
inspiration and normal expiration are plotted simultaneously) show the variation in target 
coverage and dose to organs at risk with respiration. When such bands were generated for 
a patient with high tidal volume and one with low tidal volume, it was noticed that the 
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width of the band was larger in patient with larger tidal volume than in one with low tidal 
volume indicating a higher influence of respiration on coverage in an IMRT plan. 
5.6   RECOMMENDATIONS 
IMRT to chest wall is recommended only for patients with chest wall deformities 
and in patients for whom heart sparing is of utmost importance (for eg. patients with cardiac 
comorbidities). This study showed that the heart doses with 3D CRT in left sided breast 
cancer patients crossed the tolerance limit of 10% with respiration. 
Respiratory parameters have to be assessed prior to choosing the technique of post- 
mastectomy radiotherapy. For patients with high tidal volume or chest wall movement, 3D 
CRT technique might be more beneficial in terms of target coverage in a setting where 
respiratory management techniques are not practiced. 
5.7    LIMITATIONS 
The first 16 patients with breast cancer due for post-mastectomy radiotherapy who 
consented to take part in the study were randomly recruited. Though spirometry details and 
graphs of patients maintaining inspiratory breath hold and expiratory breath hold for the 
duration of a CT scan were documented, there was no on board verification of breath hold 
during the planning CT scans. IMRT and 3D planning of only 10 out of the 16 patients 
could be completed in the stipulated time. This sample size is small to predict the 
correlation between Tidal volume and chest wall expansion with target coverage/ dose to 
organs at risk.  
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5.8     AVENUES FOR FUTURE RESEARCH 
In the Indian setting it is important to channel research towards cost effective as 
well as patient friendly treatment strategies. We have sparse knowledge on various areas 
of breast cancer radiotherapy which need future research: 
 Similar study on larger sample size is required testing the significance of the trends 
seen in  this study 
 Changes in respiratory pattern between simulation and treatment. 
 Does dosimetric research transform into information which is critical for clinical 
decision making? 
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6.    CONCLUSIONS 
6.1   MAGNITUDE OF RESPIRATORY MOTION AND ITS IMPACT 
ON BREAST CANCER RADIOTHERAPY  
 
1. The magnitude of respiratory motion varies from person to person. Respiratory 
motion definitely affects target coverage in IMRT plans when compared to 3D CRT plans. 
Dose inhomogeneity increased within the target volume with respiration and its minimal 
dose was decreased by 28% in IMRT when compared to 14% in 3D-CRT. 
2. There was a trend favouring 3D CRT technique for chest wall in patients with 
large tidal volume or chest wall expansion. However, it needs to be tested in a larger 
sample. 
3. There was definite increase in lung dose with respiration in IMRT and 3D-CRT 
techniques, but being within the tolerance limits is unlikely to cause any clinical adverse 
effect. On the other hand, volume of heart receiving 25 Gy in patients with left sided breast 
cancer crossed the tolerance limit of 10% with respiration in 3D-CRT and might be 
predictive of higher long term cardiac complication rate. Contralateral breast dose and 
integral doses were much higher with IMRT technique when compared to 3D-CRT but 
respiration had no significant effect on its magnitude. 
6.2   CONCLUDING REMARKS 
Respiration induced errors form a significant component of the total error in post-
mastectomy radiotherapy. Respiratory pattern varies greatly between individuals and hence 
it is important to consider the patient’s respiratory pattern prior to choosing the technique 
of post mastectomy radiotherapy. Larger studies are required to confirm the finding of this 
work. 
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APPENDIX 
Appendix 1 
Spirometry documentation of breath hold in inspiration and expiration 
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Appendix II 
RTOG contouring guidelines 
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Appendix III 
Information sheet 
Department Of Radiation Oncology, Unit I 
Christian Medical College & Hospital, Vellore 
 
Study Title:  To assess the impact of respiratory motion on intensity modulated 
radiation therapy to chest wall for breast cancer patients- A dosimetric analysis 
Study No            :       Subject’s Name      : 
 
Subject’s Initial :                                                       Date of Birth /Age  : 
 
You are being requested to participate in this study to see whether respiratory motion 
significantly affects radiotherapy to chest wall    
 
1.   What is this study about? 
This study aims to generate criteria for selections of patients for the various 
techniques of radiation therapy (Intensity modulated radiotherapy and 3D 
conformal tangents).  
 
2.  What is Intensity modulated radiotherapy? 
It is a technique of radiation therapy which utilizes multiple beams of varying 
intensities to treat a particular target (which will be the chest wall in this particular 
case). The advantage of this technique is that it is capable of delivering required 
radiation dose to chest wall while reducing the radiation dose to underlying lungs 
and heart. 
 
3.   What is 3D conformal tangent based radiotherapy? 
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It is a technique of radiation which utilizes multiple tangent beams to treat the chest 
wall. This technique is also capable of reducing the dose to lungs and heart to a 
certain extent. 
 
4.   Why is this study being done? 
       The movement of chest wall during respiration can adversely affect the radiation 
dose to chest wall, lungs and heart. This dose variation is not significant in all 
patients. It is proposed that patients who have a heavy breathing pattern are likely 
to have dose variations which need adjustment. Thus this study aims to document 
the effect of respiration on radiotherapy to chest wall as well as identify the 
technique which is more suitable for each patient on the basis of their respiratory 
pattern. 
 
5.   What is done in the study? 
In this study, patients will have to undergo baseline documentation of respiratory 
parameters such as Spirometry and Lung volumes. They will be trained to hold 
breath for short durations. They will then undergo simulation under fluoroscopy. 
Planning CT scan will be done at Free breathing, Inspiratory breath hold and 
Expiratory breath hold. Further analysis will be done with the use of these CT scans. 
 
6.   What is the adverse effect from taking part in this study? 
A total of 3 CT scans will be done for radiation therapy planning. An effective dose 
of 7 mSv will be absorbed by the body during each CT scan.  
 
7.   What is the chance of you developing any study related injury? 
The chance of developing study related injury is very low. Patients who will be 
recruited for this study are those who are planned for post mastectomy radiation 
therapy to chest wall. A dose of 50 Gy in 25 fractions will be delivered to chest 
wall. Thus an additional radiation exposure of 7 mSv is unlikely to have any adverse 
effect. 
 
8.   Will you have to pay for the study?  
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You will have to pay for the pre radiation therapy work up, IMRT planning and 
simulation as well as treatment charges. No additional cost will be incurred because 
study procedures are already included in the treatment cost. 
 
9.   What happens after the study is over? 
Once the CT scans are done, you are no more part of this study. You will receive 
treatment as per schedule. 
10.  Will your personal details be kept confidential? 
The results of this study might be published in a medical journal but you will not 
be identified by name in any publication or presentation of results. However, your 
medical notes may be reviewed by people associated with the study, without your 
additional permission, should you decide to participate in this study.  
 
PERSONS TO CONTACT FOR FURTHER INFORMATION AND IN 
IMMEDIATE NEED: 
 
Dr Judith Aaron, Department of Radiation Oncology, Christian Medical College, 
Vellore; (Mobile No : 9894803915) 
Dr Balukrishna S, Department of Radiation Oncology, Christian Medical College, 
Vellore 
Dr Selvamani Backianathan, Department of Radiation Oncology, Christian Medical 
College, Vellore 
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Appendix IV 
Informed consent: 
Study Number:   
Subject’s Initials:       _________             Subject’s Name: _________________________ 
Date of Birth____/____/______(DD/MM/YYYY) / Age: _______yrs  
Study Title: To assess the impact of respiratory motion on intensity modulated radiation 
therapy to chest wall for breast cancer patients- A dosimetric analysis 
 (i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not need 
my permission to look at my health records both in respect of the current study and 
any further research that may be conducted in relation to it. I agree to this access. 
However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________                Signature of the Witness: ___________ 
Date: _____/_____/______    Date: _____/_____/______ 
Study Investigator’s      Name of the Witness: 
Name: _________________________    _________________________ 
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Appendix V 
Data collection sheet 
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Appendix VI 
DATA 
NAME HOSP NO AGE BMI STAGE LATERALITY RR TV 
CHEST 
EXPANSION 
Devaki 124100c 55 29.4 II LEFT 22 0.75 1.2 
Preethal 340572f 72 28.1 II RIGHT 30 0.84 0.5 
Kamalamma 576064b 62 29 III LEFT 15 0.47 1 
Nasreen 433143f 44 29.3 II RIGHT 21 0.85 0.5 
Sabita 348507f 48 35.1 III RIGHT 19 0.59 0.5 
Thamayanthi 311522f 41 30.2 II RIGHT 21 0.75 1 
Shiny 385009f 35 22.5 II RIGHT 22 0.49 0.5 
Jesmin 432933f 53 20.9 II LEFT 18 0.6 0.5 
Ghousia 402630f 44 36.4 III RIGHT 18 0.8 0.5 
Shanthi 433413f 47 27 II LEFT 17 0.44 0.5 
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Appendix VII 
PLAGIARISM- Originality Report 
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Appendix VIII 
Institutional Review Board Approval 
  
  
- 99 - 
 
  
- 100 - 
 
  
- 101 - 
 
 
